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ABSTRACT 
 
Introduction: A strategy that combines both increasing energy expenditure and reducing 
energy intake (EI) to induce a negative energy balance is key for preventing and managing 
obesity. Exercise has been shown to reduce EI in a subsequent meal, an increase in 
temperature has also been shown to decrease appetite stimulation. Exercise in a hot 
environment may augment the appetite suppressing effect of exercise. However, there is 
currently little evidence available regarding the effect of environmental temperature during 
exercise on appetite. This study focused on the effect of exercise in different environmental 
temperatures on gut hormones and EI. 
Methods: A total of 8 healthy males completed four 5.5 hour conditions in a counterbalanced 
order. A preliminary visit consisting of a submaximal and maximal exercise test was 
conducted prior to experimental visits. For experimental visits, participants arrived in a 
fasted, euhydrated state at 08:30 and were fitted with a cannula, heart rate monitor, rectal and 
skin thermistors before completing one of four conditions: exercise in 10°C, 20°C or 30°C or 
resting control. Participants ran for 60 minutes on a treadmill at 70% of maximal oxygen 
uptake or rested for 60 minutes before resting for 4.5 hours. Blood samples were taken at 0 
(fasted), 1, 1.5, 2, 3, 4 and 5 hr. Perceptions of hunger were assessed using visual analogue 
scales at 0, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5 and 5 h. Ad libitum meals were provided at 1.5 hr and 5 
hr. 
Results: Although there was a significant reduction in relative energy intake in all exercise 
conditions (p < 0.001), this was not augmented or attenuated by any change in environmental 
temperature. This decrease was also not supported by any decrease in acylated ghrelin or 
increase in PYY. Furthermore, the only significant decrease in overall appetite was 
stimulated by the intake of food in meal 1 (p < 0.001). There was also no significant 
difference in total energy intake, lending to the notion that the decrease in relative energy 
intake can be partially, if not completely attributed to the increase in energy expenditure from 
exercise. 
Conclusion: These results suggest that exercise produces an energy deficit through a 
reduction in relative energy intake, regardless of environmental temperature. Further research 
into the effects of exercise in different environmental temperatures in an overweight and 
obese population is warranted.  
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INTRODUCTION 
 
Obesity is now the fifth leading cause of mortality worldwide (World Health Organisation, 
2009). According to the World Health Organization (WHO), in 2014 1.9 billion adults were 
overweight; 600 million of those were classified as obese. This represents a two-fold increase 
in overweight and obesity since 1980 (World Health Organisation, 2014). Obesity is defined 
as an excess of adipose tissue (Gallagher et al., 1996). A person is classified as overweight 
when their body mass index (BMI) is above 25 kg.m-2 and obese when BMI is greater than 30 
kg.m-2 (Seidell, 2000). This classification using BMI is not without issue, as although an 
indicator of body fat, BMI is not a direct measure (Gallagher et al., 1996). Overweight or 
obesity is fundamentally caused by an imbalance between energy intake (EI) and energy 
expenditure (EE). Specifically, an EI greater than EE leads to a positive energy balance and, 
if sustained, weight gain. This increase in weight can be attributed to a number of factors, 
particularly that evolution has led to a subconscious drive to eat whenever food is available 
(Bilski et al., 2009). Furthermore, high calorie foods have become more widely available 
(Charlot et al., 2017). On the other side of the energy balance equation, levels of moderate to 
vigorous physical activity have reduced and been replaced with an increase in sedentary 
behaviour, reducing EE (Hamer et al., 2014, Bilski et al., 2009). Furthermore, Tucker et al. 
(2011) suggests that as few as 10% of the population comply with physical activity 
guidelines. The substantial increase in the incidence of obesity has led to an increase in 
efforts to prevent it. In turn, this will reduce the incidence of the associated comorbidities of 
hypertension, type 2 diabetes, stroke and cancer (Greenway, 2015). It also reduces the cost to 
health and care services, predicted to increase £2 billion per year by 2030 (Wang et al., 
2011). Just as a chronic positive energy balance will increase body weight, a chronic negative 
energy balance will reduce it. Therefore, maintaining a negative energy balance is key for 
reducing body weight to manage obesity. A negative energy balance is achieved when total 
energy expenditure (TEE) is greater than EI (Hill et al., 2012). Total energy expenditure is 
the sum of resting metabolic rate, the thermic effect of food and energy expended during 
physical activity (Hill et al., 2012).  
Reducing EI through diet restriction is the most common intervention for the management of 
obesity (Ross et al., 2000). Known commonly as ‘dieting’, this often results in transient 
weight loss, especially in those utilising very-low-energy diets (Greenway, 2015, Anderson et 
al., 2001). Weight regain may occur through weight loss-induced changes in appetite 
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regulatory hormones, increases in ghrelin and decreases in PYY and GLP-1 sustained for a 
minimum of a one year period (Greenway, 2015, Sumithran et al., 2011). Therefore, 
maintaining weight loss is just as vital as the initial weight loss. 
Energy expenditure from physical activity is the most practical component of EE to 
manipulate, and is commonly achieved by increasing levels of physical activity through 
exercise (Curioni & Lourenco, 2005). Independent of weight loss, exercise also aids the 
prevention of cardiovascular disease (Fletcher et al., 1992), type 2 diabetes, cancer, 
osteoporosis (Warburton et al., 2006) and has psychological benefits (Martinsen, 1990). 
Previous studies have indicated that individuals do not offset the amount of energy expended 
by increasing EI in the subsequent hours following exercise (Faure et al., 2016, Schubert et 
al., 2013). This phenomenon of exercise related acute reduction in hunger has been termed 
‘exercise induced anorexia’, and coincides with increases in PYY and a decrease in acylated 
ghrelin (Larson-Meyer et al., 2012, Bilski et al., 2009, Ueda et al., 2009a). These individuals 
would be at an energy deficit which, if maintained, would lead to weight loss. A strategy that 
combines both increasing EE and reducing EI has the potential to be a key tool in preventing 
and managing obesity; this combination has also been shown to aid in the maintenance of 
weight loss (Curioni & Lourenco, 2005). 
In addition to exercise, it is also possible to alter appetite, therefore potentially EI, through 
the manipulation of environmental temperature. In the cold, Westerterp-Plantenga et al. 
(2002) detected a significantly greater EE in participants resting for 60 hours in 16°C 
compared to resting in 22°C, attributed to an increase in resting metabolic rate. This increase 
was not compensated for by an increase in EI, resulting in an energy deficit. Regarding the 
effect of heat on appetite, Faure et al. (2016) detected lower plasma acylated ghrelin 
following 40 minutes rest in the heat (31°C) compared to resting in a neutral temperature 
(22°C), suggesting a reduction in appetite stimulation, therefore, lower EI. Anecdotally, 
individuals do also report having a reduced appetite in the heat. Clearly, there is very little 
literature available on the independent effects of temperature on appetite.  Despite this lack of 
literature, the manipulation of environmental temperature clearly has the potential to alter 
appetite. 
The appetite suppressing effects of exercise and a manipulation of environmental temperature 
have the potential, if combined, to provide guidelines for weight control. This combination of 
an exercise intervention and manipulation of environmental temperature has been previously 
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investigated to a limited extent (Kojima et al., 2016, Faure et al., 2016, Crabtree & Blannin, 
2015, Wasse et al., 2013, Shorten et al., 2009). However, the few available studies have 
produced contradictory findings and included considerable limitations. Faure et al. (2016), 
Kojima et al. (2015), Wasse et al. (2013) and Shorten et al. (2009) investigated the effect of 
exercise in the heat compared to exercise in a neutral environmental temperature. Wasse et al. 
(2013) detected a significant decrease in EI in an ad libitum meal after exercise in the heat 
compared to a neutral temperature, this was accompanied by lower perceptions of hunger but 
not a decrease in acylated ghrelin. Faure et al. (2016) and Shorten et al. (2009) also detected 
lower, but not significant, energy intake after exercise in the heat compared to exercise in a 
neutral temperature. Kojima et al. (2015) detected a significant decrease in perceived hunger 
following exercise in the heat compared to exercise in a neutral environmental temperature, 
but did not measure energy intake.  
Crabtree & Blannin (2015), Kojima et al. (2015) and Wasse et al. (2013) also examined the 
effect of exercise in the cold. Crabtree & Blannin (2015) detected a significant increase in EI 
and a significant increase in acylated ghrelin after exercise in the cold compared to exercise 
in a neutral environmental temperature. Wasse et al. (2013) showed a higher, but not 
significant, EI after exercise in the cold and also detected lower perceived appetite but did not 
find any differences in gut hormones. The findings in the Wasse et al. (2013) study are 
conflicting, as it is expected that lower perceptions of appetite coincide with lower EI, 
however this was not the case. 
However, these studies are limited by not comparing experimental conditions to a resting 
control trial (Kojima et al., 2016, Faure et al., 2016, Crabtree & Blannin, 2015, Wasse et al., 
2013, Shorten et al., 2009). Therefore, the aim of the current study was to investigate the 
effect of exercise in different environmental temperatures on gut hormones and EI, and 
compare those effects to a resting control.  
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AIMS AND HYPOTHESES 
 
The aims of this study were to: 
a) Investigate the effect of an acute bout of running exercise in different environmental 
temperatures on perceived appetite and gut hormones. 
b) Investigate the effect of an acute bout of running exercise in different environmental 
temperatures on ad libitum EI. 
 
The hypotheses are as follows: 
a) Exercise in the heat will augment the appetite-suppressing effect of exercise, while 
exercise in a cold environment will attenuate the appetite-suppressing effect of 
exercise when compared to exercise in a neutral temperature.  
b) If exercise does reduce energy intake, this effect will be greatest when combined with 
an increase environmental temperature compared to exercise in a neutral 
environmental temperature. A decrease in environmental temperature will reduce the 
effect of exercise on energy intake compared to exercise in a neutral environmental 
temperature.   
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LITERATURE REVIEW 
 
This section aims to give a brief overview of factors affecting appetite control before 
conducting a review of the current literature regarding the influence of gut hormones in 
appetite regulation. Furthermore, this section will discuss the independent effects of aerobic 
exercise and environmental temperature on appetite and appetite control, and will end with an 
examination of the combined effect of environmental temperature and aerobic exercise on 
appetite and its regulation. 
 
Appetite Control 
Appetite control is an intricate homeostatic process that at a physiological level includes gut 
hormones, the brain and other organs (Klok et al., 2007). It should also be acknowledged that 
there is an environmental, social and psychological aspect to appetite control and it is 
possible that these factors can override the physiological mechanisms (Cruwys et al., 2015, 
Martins et al., 2008, Saper et al., 2002). For example, it has been shown that when exposed to 
their peers eating larger portions, individuals will eat more than if eating alone, thus 
demonstrating a so-called ‘modelling’ effect (Nisbett & Storms, 1974). Furthermore, the 
process of evolution has resulted in an innate need to eat whenever food is available, and 
even the mere thought, sight or smell of food can begin the body’s preparation for food intake 
(Bilski et al., 2009). Despite this plethora of factors affecting appetite control, it has been 
shown that changes in those gut hormones can reduce energy intake (Druce et al., 2006, 
Degen et al., 2005). 
 
Appetite-Regulating Hormones 
Several hormones are involved in appetite regulation in humans; some are anorectic such as 
peptide tyrosine-tyrosine (PYY). In contrast, acylated ghrelin is, to date, the only orexigenic 
(appetite-stimulating) gut hormone to be discovered (Kojima et al., 1999). Previous literature 
suggests it is possible to alter the balance of the gut hormones PYY and acylated ghrelin to 
provide a significant decrease in appetite through manipulation of environmental temperature 
or exercise (Schubert et al., 2014, Schubert et al., 2013). 
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Acylated Ghrelin 
Ghrelin is present in the body in both acylated and nonacylated forms, with 80-90% being 
nonacylated, and only about 10% being acylated (Broom et al., 2007, Al Awar et al., 2005). 
However, only the active form of ghrelin, acylated ghrelin, can bind to growth hormone 
secretagogue receptor (GHS-R1a) and cross the blood-brain barrier to stimulate appetite 
(Albarrn-Zeckler & Smith, 2013, Neary & Batterham, 2009, Broom et al., 2007, Banks et al., 
2002). Acylated ghrelin is a 28-amino acid peptide hormone and is currently the only 
hormone that is known to stimulate hunger in humans (Neary & Batterham, 2009, Broom et 
al., 2007). Acylated ghrelin was not widely measured, due to its instability and relatively 
short half-life of 9-13 minutes (Akamizu et al., 2004), until Hosoda et al. (2004) developed a 
method of stabilising and preserving acylated ghrelin beyond this half-life. 
Acylation is the process of adding an acyl group to the third serine residue of ghrelin, 
forming acylated ghrelin (Kojima et al., 1999). This reaction is catalysed by the enzyme 
ghrelin-O-acyltransferase (GOAT), which has been detected in the circulatory system of 
humans, suggesting ghrelin is synthesised and acylated in different locations in the body 
(Prinz & Stengel, 2017, Yang et al., 2008). Ghrelin is released predominantly from the 
gastric oxyntic glands in the stomach and to a lesser extent, the small intestine, pancreas and 
hypothalamus (Neary & Batterham, 2009, Broom et al., 2007). The stomach is the main 
source of ghrelin synthesis, with gastrectomy in rats showing a large reduction in circulating 
ghrelin (Ariyasu et al., 2001). In humans, Cummings et al. (2002) investigated differences in 
total ghrelin secretion among obese individuals undergoing weight loss through dieting and 
those post-gastric bypass surgeries. The elevated meal response was present in all 
individuals; however, the total 24-hour ghrelin profile in the gastric bypass group was 77% 
lower than the dieting group. This study not only suggests that a reduction in circulating total 
ghrelin may contribute to weight loss, but also that bypassing the stomach severely limits the 
body’s ability to produce and secrete ghrelin. This is further evidenced as acylated ghrelin 
acts on the gastric afferent vagal nerve to stimulate feeding in rats, with Date et al. (2002) 
showing no increase in feeding following intravenous administration of total ghrelin after a 
blockade of the vagal afferent. 
Supporting evidence for acylated ghrelin being orexigenic comes from findings in several 
studies that plasma acylated ghrelin concentrations rise in the pre-prandial phase and fall in 
the postprandial phase (Cummings et al., 2002). Al Awar et al. (2005) showed that fasting 
plasma acylated ghrelin levels decrease within 15 minutes of EI, reaching the lowest 
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concentrations approximately 30 minutes postprandial; concentrations then begin to rise after 
60 minutes and surpass fasting levels after 180 minutes. Nonacylated ghrelin may play a role 
in stimulating adipogenesis (Heppner et al., 2014, Thompson et al., 2004) and has been 
shown to enhance gastric motility in humans (Wren et al., 2001a). Furthermore, Tong et al. 
(2013) suggest a role for nonacylated ghrelin in glucose homeostasis, detecting a significant 
decrease in insulin secretion with no change to insulin sensitivity in response to nonacylated 
ghrelin infusions. Nonacylated ghrelin has also been shown to stimulate gastric acid secretion 
in rats (Masuda et al., 2000). There is also a suggestion that nonacylated ghrelin aids 
regulation of body temperature; Inoue et al. (2013) showed a significant decrease in the back 
temperature and vasodilation in the tails of rats following a central infusion of nonacylated 
ghrelin, suggesting an increase in nonacylated ghrelin may limit the body’s ability to 
effectively reduce temperature. Therefore, studies involving a manipulation of environmental 
temperature should consider the functions of non-acylated ghrelin.  
Studies into rats and humans that have supplied an acylated ghrelin infusion to participants 
provide evidence that acylated ghrelin is orexigenic. Firstly, in rats, Nakazato et al. (2001) 
showed that an intracerebroventricular (ICV) injection of total ghrelin to 8 hour fasted rats 
promoted a four-fold increase in food intake over a two-hour period compared to a saline 
injection. Wren et al. (2001b) found that a similar ICV injection of total ghrelin once daily 
stimulated a 15 g increase in body weight over seven days in rats compared to a 2 g increase 
over seven days of ICV saline injections. Also in rats, Tschöp et al. (2000) showed that total 
ghrelin administration promoted a significant increase in EI and a subsequent weight 
increase. In humans, Druce et al. (2006) found a 27% increase in EI 60-minutes after a 
subcutaneous injection of total ghrelin compared to the same dose of saline in healthy men 
and women. Wren et al. (2001a) also showed a 28% increase in EI when nine participants 
received a subcutaneous total ghrelin infusion compared to saline infusion. From this 
evidence, it seems reasonable to conclude that acylated ghrelin stimulates appetite in humans. 
The response of acylated ghrelin to EI differs according to the macronutrient composition of 
the food ingested. Carbohydrate intake has a greater suppressive effect on acylated ghrelin 
than protein or fat (El Khoury et al., 2006). Furthermore, acylated ghrelin has been shown to 
respond more quickly to carbohydrate intake than total ghrelin (Hosoda et al., 2004).  In 
contrast, it has been reported that fat intake does not significantly decrease plasma acylated 
ghrelin concentrations (Al Awar et al., 2005, Tentolouris et al., 2004). However, Broom et al. 
(2007) reported a decrease in acylated ghrelin following a meal consisting of 38% 
 8 
carbohydrate, 10% protein and 52% fat. It is possible that the carbohydrate in this meal 
exerted much of the suppressive effect on acylated ghrelin. Furthermore, this study involved 
an exercise intervention that may have suppressed acylated ghrelin prior to the meal (Broom 
et al., 2007). This difference in macronutrient response indicated that it is vital for studies 
that are measuring acylated ghrelin and ad libitum EI following an exercise intervention to 
consider the macronutrient composition of the test meals provided. 
Peptide YY 
Named because of the presence of the amino acid tyrosine at each terminus of the 
polypeptide, peptide tyrosine-tyrosine (PYY) is an anorectic hormone responsible for 
stimulating satiety in humans (Karra & Batterham, 2010). PYY is predominantly synthesised 
and secreted from specialised L-cells in the small intestine and colon (Prinz & Stengel, 2017, 
Karra & Batterham, 2010). Two forms of PYY, PYY1-36 and PYY3-36, are present in the body 
in both the fasted and fed states. PYY3-36 forms most circulating PYY in both states (Grandt 
et al., 1994).  
Evidence proposing that PYY is anorectic in nature has come from studies showing that 
plasma PYY concentrations rise in response to EI. Levels initially rise 15 minutes after 
nutrient ingestion and peak after 1 to 2 hours, followed by a plateau lasting several hours 
(Adrian et al., 1985). Further support for the satiating effects of PYY is the reduction in 
appetite following PYY administration; Degen et al. (2005) showed a 32% reduction in EI 
following subcutaneous PYY infusion compared to saline. Furthermore, Gantz et al. (2007) 
showed a significant decrease in body weight over a 12-week period of intranasal PYY 
administration 20 minutes before every meal. It has been shown that PYY3-36 acts as a satiety 
signal by binding the neuropeptide Y Y2 receptor (Y2R) in the arcuate nucleus of the 
hypothalamus (Batterham et al., 2002). Evidence for this suggestion is supplied by studies 
showing that PYY administration reduced EI in normal mice but not in Y2R-null mice 
(Batterham et al., 2002). Due to this evidence, it seems clear that PYY acts on the CNS as a 
satiety signal in humans. 
Meals of different macronutrient composition have been shown to have varying postprandial 
effects on plasma PYY (Helou et al., 2008). Fat intake appears to increase PYY within an 
hour and to the greatest extent, while protein intake delays the increase until after the first 
hour (Helou et al., 2008). Helou et al. (2008) showed that a meal high in carbohydrate (60% 
carbohydrate, 20% fat, 20% protein) sustained the increase in PYY above baseline over a test 
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period of three hours. The combined effects show that a balanced meal (50% carbohydrate, 
30% fat, 20% protein) has the potential to stimulate an increase in PYY over an extended 
period. These findings make it clear that since fat produces the most pronounced PYY 
response, meal composition should be carefully considered when comparing studies 
measuring changes in PYY for differences in composition of test meals that may alter the 
postprandial response.  
 
Effect of acute aerobic exercise on gut hormones, appetite and energy intake 
The effect of aerobic exercise on appetite has been widely studied, with the consensus from 
experimental research (Kojima et al., 2016, Douglas et al., 2015, Larson-Meyer et al., 2012, 
King et al., 2010, Ueda et al., 2009a, Broom et al., 2007, Burns et al., 2007, Jurimae et al., 
2007, Martins et al., 2007, Dall et al., 2002) and meta-analyses (Schubert et al., 2014, 
Schubert et al., 2013) being that appetite is acutely reduced by aerobic exercise. 
Acylated Ghrelin 
The effect of exercise on acylated ghrelin concentrations is an area of debate, with some 
studies showing a significant decrease in concentrations (Kojima et al., 2016, Larson-Meyer 
et al., 2012, King et al., 2010, Broom et al., 2007) and others showing no difference from a 
control trial (Douglas et al., 2015). However, many studies are now of reduced significance 
due to not measuring the active, acylated form of ghrelin (Larson-Meyer et al., 2012, Burns 
et al., 2007, Jurimae et al., 2007, Martins et al., 2007, Dall et al., 2002). Information on the 
participants, conditions and results of these studies is presented in table 1. 
Several studies focusing on the effect of a single bout of aerobic exercise on plasma acylated 
ghrelin have produced comparable findings. Kojima et al. (2016), Larson-Meyer et al. 
(2012), King et al. (2010) and Broom et al. (2007) all detected a transient, yet significant 
decrease in plasma acylated ghrelin following exercise interventions ranging from 40-90 
minutes in duration and at an intensity greater than 60% of ?̇?O2max. Conversely, Douglas et 
al. (2015) did not show a significant difference on day one of a two-day trial, measuring 
acylated ghrelin at 0 (baseline) and 7 hours (end of trial day 1) despite using an exercise 
protocol similar in intensity and duration. The first post-exercise Douglas et al. (2015) blood 
sample was at hour 7, following two ad libitum meals, had this study analysed plasma 
acylated ghrelin within the 30-minutes post-exercise, a significant difference may have been 
detected. These findings support the theory that any exercise induced decrease in acylated 
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ghrelin is transient. In the studies that detected a significant decrease in plasma acylated 
ghrelin, concentrations were only significantly different for up to 30 minutes after the end of 
exercise (Kojima et al., 2016, Larson-Meyer et al., 2012, King et al., 2010, Broom et al., 
2007). Significant suppression of acylated ghrelin was not sustained beyond this time in any 
study to date. The majority of these findings support a suggestion from Bilski et al. (2009) 
that intense exercise, greater than 60% of ?̇?O2max, causes a short-term suppression of appetite 
through an decrease in secretion of acylated ghrelin. 
In addition to measuring plasma acylated ghrelin, numerous studies have assessed the 
response of total ghrelin to an acute bout of aerobic exercise, however none of these studies 
detected a significant difference in total ghrelin following acute aerobic exercise (Larson-
Meyer et al., 2012, Burns et al., 2007, Jurimae et al., 2007, Martins et al., 2007, Kraemer et 
al., 2004). The difference in response to exercise between acylated and total ghrelin may be 
explained by the acylation of nonacylated ghrelin already present in the body at the time of 
exercise. This would have the effect of maintaining plasma total ghrelin while the ratio of 
acylated to nonacylated ghrelin increased. This theory is supported by Larson-Meyer et al. 
(2012), detecting a significant decrease in acylated ghrelin but no change in total ghrelin, 
suggesting the acylation of ghrelin is inhibited during exercise. Furthermore, it has been 
postulated that a low, rather than high intensity exercise has the greater effect on total ghrelin 
response. This suggestion is due to studies conducted by Erdmann et al. (2007) and Dall et al. 
(2002), Erdmann et al. (2007) showed a significant change in plasma total ghrelin using low 
intensity cycling (50 W), while Dall et al. (2002) exercised participants at a high intensity 
(175 W). However, Erdmann et al. (2007) utilised an exercise duration of 120 minutes, while 
Dall et al. (2002) exercised participants for only 45 minutes. This raises the question if 
exercise intensity or duration has the greater effect on plasma total ghrelin. The consensus 
from the previous literature is that despite having no effect on total ghrelin, an acute bout of 
aerobic exercise of 60 minutes in duration and an intensity of 60% of ?̇?O2max or greater has a 
significant suppressive effect on plasma acylated ghrelin (Schubert et al., 2014). 
Peptide YY 
Current literature suggests that aerobic exercise acutely increases plasma PYY 
concentrations. Research conducted by Ueda et al. (2009a) and Martins et al. (2007) shows a 
significant increase in plasma PYY compared to a control condition following exercise at a 
minimum of 60% of ?̇?O2max lasting at least 30 minutes. Following 30 minutes exercise at 
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75% of ?̇?O2max PYY AUC was 16 times greater than PYY AUC after 30 minutes rest (Ueda 
et al. (2009a). PYY levels increased during exercise and remained elevated for the following 
30 minutes in both studies (Ueda et al., 2009a). Monitoring was ceased 30 minutes post 
exercise in both studies; thus, it may have been possible to observe a prolonged effect of 
exercise had monitoring been continued. In contrast, Kojima et al. (2016) showed no 
significant difference in plasma PYY concentrations following a 20-km run, despite this 
being of a greater intensity and duration than the afore mentioned studies. The discrepancy in 
results between these studies may be explained by the fact that PYY concentrations were 
already significantly lower at baseline in the exercise condition of the Kojima et al. (2016) 
study than the control condition. This may have had the effect that despite a rise in plasma 
PYY concentrations no significance was detected. Furthermore, it has been shown that 
aerobic, but not resistance exercise, stimulates an increase in plasma PYY concentrations 
(Broom et al., 2009). Broom et al. (2009) investigated the effects of 90-minutes resistance 
training and 60-minutes aerobic exercise on PYY concentrations. PYY was significantly 
increased in the aerobic exercise condition, but was not different in the resistance exercise 
condition from the resting control. However, EE in the aerobic condition was 2.6 times 
greater than that of the resistance condition, raising questions of whether the increased EE or 
the mode of exercise increased PYY concentrations. Nevertheless, it is clear that aerobic 
exercise acutely increases plasma PYY concentrations. 
Perceptions of appetite 
Human appetite can be broken down into four facets; hunger - the feeling of starvation 
signalling that an individual should eat, satiation - the process that leads to the termination of 
eating, fullness - the feeling of the stomach being full, and prospective food consumption 
(PFC) - the amount of food an individual expects to consume (Sørensen et al., 2003). 
Subjective perceptions of hunger, satiation, fullness and prospective food consumption are 
commonly assessed by visual analogue scales (VAS); an “overall appetite” rating is also 
often calculated as the mean after inverting the values of satiation and fullness (Blundell et 
al., 2010, Stubbs et al., 2000). Visual analogue scales are lines of 10 cm in length with an 
extreme at each end (‘Not at all full’ and ‘Totally full’) and participants make a single mark 
along the line. The distance from the left end of the line to the mark is measured and recorded 
as a percentage (Flint et al., 2000). Visual analogue scales have been used extensively to 
assess changes in appetite in response to exercise (Kojima et al., 2016, Douglas et al., 2015, 
Larson-Meyer et al., 2012, King et al., 2010, Ueda et al., 2009a, Martins et al., 2007, Jurimae 
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et al., 2007, Burns et al., 2007, Broom et al., 2007, Dall et al., 2002). Previous literature 
suggests that hunger and PFC are suppressed, satiety and fullness increased during and 
immediately after exercise (Kojima et al., 2016, Ueda et al., 2009a, Martins et al., 2007, 
Burns et al., 2007) but these effects are rarely sustained longer than 30 minutes (Kojima et 
al., 2016). 
Energy intake 
Energy intake is a key variable in appetite research, as regardless of changes in gut hormones 
and perceptions of hunger, if the actual amount of energy consumed is not altered these 
changes are meaningless. The effect of exercise on total EI is an area of dispute with some 
studies reporting a significant decrease in EI following exercise when compared with a 
resting control trial (Kojima et al., 2016, Ueda et al., 2009a), others report no difference 
(Douglas et al., 2015, Larson-Meyer et al., 2012, King et al., 2010) and some even report an 
increase following exercise (Shorten et al., 2009, Martins et al., 2007). 
Of the studies that report EI, those observing a significant decrease as a result of exercise 
used the greatest exercise intensities, a 20 km run reduced EI 13% (Kojima et al., 2016), and 
Ueda et al. (2009a) also detected a significant decrease in EI after a 30 minute treadmill run 
at 75% of ?̇?O2max, but did not report exact figures for EI. These findings complement the 
reduction in subjective appetite often found during and immediately post-exercise (Bilski et 
al., 2009).  However, subjective ratings of appetite do not always correlate with EI. For 
example, Douglas et al. (2015) detected a significant decrease in ratings of hunger, but this 
did not relate to any decrease in EI following exercise. Although, these variables do link a 
reduction in EI and subjective feelings of appetite in other research articles (Kojima et al., 
2016, Ueda et al., 2009a, Martins et al., 2007), this may suggest that the use of VAS to assess 
appetite is a poor predictor of EI. 
However, when EI is offset against energy expended during exercise, a decrease after 
exercise compared to a control is often observed (Kojima et al., 2016, Douglas et al., 2015, 
Larson-Meyer et al., 2012, King et al., 2010, Martins et al., 2007). The offset EI is known as 
relative energy intake (REI). This would lead to a negative energy balance in the short term 
(Schubert et al., 2013). 
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Table 1: Effect of acute aerobic exercise on gut hormones, appetite and energy intake.  
Author Participants Conditions Energy Intake Ghrelin PYY Hunger 
   Absolute Relative Total Acylated   
Kojima et al. 
(2016) 
23 male 
college 
endurance 
runners 
 
EX - 20 km 
outdoor run 
CON - 120 
min rest 
 
EX = 1325 ± 
55 
CON = 1529 
± 55 (kcal) * 
13% fewer 
kcal 
consumed in 
EX * 
NR 
No difference 
between EX 
and CON 
No difference 
between EX 
and CON 
EX = 60 ± 5 
CON = 71 ± 
3 (mm) * 
Douglas et al. 
(2015) 
15 physically 
active males 
 
EX - 60 min, 
70% ?̇?O2max 
treadmill run 
CON - 60 
min rest 
 
EX = 2802 ± 
780 
CON = 2893 
± 756 (kcal) 
EX = 760 ± 
140 
CON = 986 ± 
158 (kcal) * 
NR 
No difference 
between EX 
and CON 
No difference 
between EX 
and CON 
Lower in EX 
than CON * 
Larson-
Meyer et al. 
(2012) 
9 trained 
females 
 
EX - 60 min, 
70% ?̇?O2max 
treadmill run 
CON - 60 
min rest 
 
EX = 485.8 ± 
183.4 
CON = 480.4 
± 126.4 
(kcal) 
EX = -193.9 
± 205.8 
CON = 283.8 
± 120.6 
(kcal) * 
EX = 144.7 ± 
52.6 
CON = 167.8 
± 37.0 
(pmol/L) 
EX = 10.6 ± 
8.6 
CON = 25.4 
± 15.7 
(pmol/L) * 
EX = 45.0 ± 
8.9 
CON = 43.6 
± 10.9 
(pmol/L) 
EX = 8.9 ± 
9.4 
CON = 13.6 
± 16.4 
King et al. 
(2010) 
9 healthy 
males 
 
EX - 90 min, 
70% ?̇?O2max 
treadmill run 
CON - 90 
min rest 
 
EX = 3898 ± 
484 
CON = 4854 
± 416 (kcal) 
 
EX = 2935 ± 
299 
CON = 4109 
± 273 (kcal) 
* 
NR 
EX = 130.3 ± 
15.1 
CON = 147.1 
± 19.7 
(pg/ml) * 
NR 
EX = 74 ± 5 
CON = 65 ± 
8 (mm) 
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Broom et al. 
(2009) 
11 healthy 
males 
 
EX - 60 min, 
70% ?̇?O2max 
treadmill run 
CON - 60 
min rest 
 
NR NR NR 
EX = 188 ± 
68 
CON = 228 ± 
62 (pg/ml) 
EX = 324 ± 
54 
CON = 229 ± 
29 (pg/ml) * 
Lower in EX 
than CON * 
Shorten et al. 
(2009) 
11 healthy 
males 
 
EX - 40 min, 
70% ?̇?O2max 
treadmill run 
CON - 40 
min rest 
 
EX = 954 ± 
377 
CON = 678 ± 
244 (kcal) * 
No difference 
between EX 
and CON 
NR 
No difference 
between EX 
and CON 
No difference 
between EX 
and CON 
NR 
Ueda et al. 
(2009a) 
10 young 
males 
EX50 - 30 
min, 50% 
?̇?O2max 
treadmill run 
EX75 - 30 
min, 75% 
?̇?O2max 
treadmill run 
CON - 30 
min rest 
 
Lower in 
EX50 and 
EX75 than 
CON * 
NR NR NR 
EX75 = 
446.8 ± 187.0 
EX50 = 
293.4 ± 171.9 
CON = 26.7 
± 16.2 
(pmol/ml60
min) * 
Lower in 
EX50 and 
EX75 
compared to 
CON * 
Broom et al. 
(2007) 
9 healthy 
males 
EX - 60 min, 
75% ?̇?O2max 
treadmill run 
CON - 60 
min rest 
 
NR NR NR 
38% lower in 
EX than 
CON * 
NR 
No difference 
between EX 
and CON 
 15 
Burns et al. 
(2007) 
18 healthy 
males and 
females 
EX - 60 min, 
75% ?̇?O2max 
treadmill run 
CON - 60 
min rest 
NR NR 
 
EX = 1240.7 
± 179.8 
CON = 
1374.9 ± 
231.7 
(pmol/L) 
 
NR NR 
Reduced 
during and 
after exercise 
in EX and 
CON * 
Martins et al. 
(2007) 
12 healthy 
males and 
females 
 
EX - 60 min, 
65% maxHR 
cycle 
CON - 60 
min rest 
 
EX = 913 ± 
363 
CON = 762 ± 
252 (kcal) * 
EX = 421 ± 
302 
CON = 565 ± 
226 (kcal) * 
No difference 
between EX 
and CON 
NR 
Increased in 
EX * 
Decreased in 
EX * 
* indicates statistical significance (p < 0.05) exact figures stated when reported, relative energy intake calculated as energy intake minus energy expenditure, NR – not 
reported 
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Effect of temperature at rest on gut hormones, appetite and energy intake 
The effect of environmental temperature on appetite is an area that has not been widely 
examined with only three research studies examining the effect of environmental temperature 
at rest on appetite (table 2) (Faure et al., 2016, Langeveld et al., 2016, Westerterp-Plantenga 
et al., 2002). This said, anecdotal evidence suggests appetite decreases in the heat and 
increases in the cold when compared to a thermoneutral condition (Charlot et al., 2017).  
Effect of heat on gut hormones, appetite and energy intake 
To date, only one study has investigated the effect of heat during rest on appetite (Faure et 
al., 2016). The general findings of this study indicate that there is no significant effect of heat 
(31°C) during rest for 100 minutes on EI or relative energy intake (REI). However, there was 
a trend for lower perceptions of hunger in the heat compared to a neutral control (22°C). 
Effect of cold on gut hormones, appetite and energy intake 
There are currently two studies that have examined the response of appetite to a cold 
environment at rest (Langeveld et al., 2016, Westerterp-Plantenga et al., 2002). These two 
studies observed similar findings despite using slightly different temperatures that may be 
considered too high to be “cold” (16 and 18°C) (Charlot et al., 2017). The two studies by 
Langeveld et al. (2016) and Westerterp-Plantenga et al. (2002) also exposed participants to 
the experimental environmental temperature for drastically different periods of time, the 
Langeveld et al. (2016) study lasted for 150 minutes while Westerterp-Plantenga et al. (2002) 
exposed participants for 60 hours. However, both studies reported an increase in EE when 
resting in the cold through a greater resting metabolic rate. Also, both studies reported no 
increase in EI when compared to a resting control trial. These findings show that individuals 
do not compensate for the increase in EE in the cold by increasing EI. Furthermore, due to 
the difference in duration, the mechanisms involved in short term appetite control in the cold 
may differ from those involved in long term appetite control. 
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Table 2: Effect of environmental temperature on gut hormones, appetite and energy intake. 
Author Participants Conditions Energy Intake Ghrelin PYY Hunger 
   Absolute Relative Total Acylated   
Faure et al. 
(2016) 
10 healthy 
men 
HEAT - 100 
min rest in 
31°C 
CON - 100 
min rest in 
22°C 
 
HEAT = 
1039 ± 217 
CON = 1042 
± 330 (kcal) 
No difference 
between 
HEAT and 
CON 
No difference 
between 
HEAT and 
CON 
NR NR 
No difference 
between 
HEAT and 
CON 
Langeveld et 
al. (2016) 
10 healthy 
males and 
females 
COLD - 150 
min rest in 
18°C 
CON - 150 
min rest in 
24°C 
 
COLD = 688 
± 118 
CON = 655 ± 
136 (kcal) 
NR NR NR NR 
No difference 
between 
COLD and 
CON 
Westerterp-
Plantenga et 
al. (2002) 
9 healthy 
males 
COLD - 60 
hours rest in 
16°C 
CON - 60 
hours rest in 
22°C 
 
COLD = 
7588 ± 1195 
CON = 7110 
± 1315 
NR NR NR NR 
No difference 
between 
COLD and 
CON 
* indicates statistical significance (p < 0.05) exact figures stated when reported, relative energy intake calculated as energy intake minus energy expenditure, NR – not 
reported 
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Combined effect of environmental temperature and exercise on gut hormones, appetite 
and energy intake 
The effect of environmental temperature during exercise is an area that has been investigated 
by a small number of studies previously (table 3) (Faure et al., 2016, Crabtree & Blannin, 
2015, Kojima et al., 2015, Wasse et al., 2013, Shorten et al., 2009). Some studies have 
observed the effects of exercise in the cold, neutral and the heat. However, none of these 
studies have compared the effect of exercise in heat, cold and neutral temperatures to a 
resting control. 
Effect of heat and exercise on gut hormones, appetite and energy intake 
The effect of heat during exercise has been investigated in several recent research articles 
(Faure et al., 2016, Kojima et al., 2015, Wasse et al., 2013, Shorten et al., 2009). These 
studies generally conclude that exercising in the heat does not augment the appetite 
suppressing effect of exercise and are summarised in Table 3. 
Before commenting on the effects of exercise in the heat it is necessary to note the differing 
temperatures that are referred to as ‘heat’ exposure. Temperatures ranging from 30°C (Wasse 
et al., 2013) to 36°C (Kojima et al., 2015, Shorten et al., 2009) are utilised to expose 
individuals to the heat. Therefore, care must be taken when comparing studies investigating 
exercise in the heat. Furthermore, a range of exercise intensities and modes are also used. 
Most commonly used are cycling and running at intensities between 60 and 70% of ?̇?O2max 
(Faure et al., 2016, Kojima et al., 2015, Wasse et al., 2013, Shorten et al., 2009), however 
walking has also been used when investigating an overweight population (Crabtree & 
Blannin, 2015).  
Gut Hormones 
None of the studies to investigate the effect of exercise in the heat on appetite detected a 
significant difference in acylated ghrelin or PYY during or after exercise in the heat 
compared to a neutral temperature (Kojima et al., 2015, Wasse et al., 2013, Shorten et al., 
2009). These studies also did not detect any difference in total ghrelin. It is not possible to 
examine the magnitude of change caused by either the exercise or the heat in these studies, as 
none included a control trial. 
Energy intake 
The effect of exercise in the heat on absolute EI is assessed in three studies (Faure et al., 
2016, Wasse et al., 2013, Shorten et al., 2009). Faure et al. (2016) and Shorten et al. (2009) 
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did not observe a difference in absolute EI, however Wasse et al. (2013) detected a decrease 
after exercise in the heat compared to exercise in a neutral temperature. The difference 
detected in this study may be due to the greater duration of exercise (Shorten et al., 2009) or 
greater intensity and different mode of exercise, cycling in the Faure et al. (2016) study and 
treadmill running in the Wasse et al. (2013) study. The response of appetite to running and 
cycling has not widely been investigated, the effect of these two modes of exercise may 
differ, possibly due to a difference in active muscle mass. None of these studies detected a 
significant difference in REI (Kojima et al., 2015, Wasse et al., 2013, Shorten et al., 2009). 
Effect of cold and exercise on gut hormones, appetite and energy intake 
The effect of exercise in the cold has not been widely examined (Crabtree & Blannin, 2015, 
Kojima et al., 2015, Wasse et al., 2013). As with exercise in the heat, these studies generally 
conclude that exercise in the cold does not affect appetite. 
Acylated Ghrelin 
Crabtree & Blannin (2015), Kojima et al. (2015) and Wasse et al. (2013) investigated the 
effect of exercise in the cold on plasma acylated ghrelin. Crabtree & Blannin (2015) was the 
only study to detect a change, however this was a significant increase after exercise. This 
could be due to the exercise being the lowest intensity of the studies, this may affect changes 
in acylated ghrelin as studies detecting changes all used exercise intensities of at least 70% 
?̇?O2max. However, these changes have previously been detected after exercise independently 
of manipulation of environmental temperature (King et al., 2010, Broom et al., 2009, Broom 
et al., 2007). 
Peptide Tyrosine-Tyrosine 
Crabtree & Blannin (2015) and Kojima et al. (2015) also investigated the effect of exercise in 
the cold on plasma PYY. However, neither Crabtree & Blannin (2015) or Kojima et al. 
(2015) detected a significant difference in PYY after exercise in the cold compared to 
exercise in a neutral environment. Once again, these studies cannot be compared to a resting 
trial as Crabtree & Blannin (2015) nor Kojima et al. (2015) included a control trial. 
Perceptions of hunger 
Wasse et al. (2013) and Kojima et al. (2015) investigated the effect of exercise in the cold on 
perceived hunger. These studies produced conflicting findings; Kojima et al. (2015) detected 
a significant increase in perceived hunger, whereas Wasse et al. (2013) detected a decrease. 
This may be due to differences in exercise duration and mode, Wasse et al. (2013) used the 
whole body exercise of running for 60 minutes, 15 minutes greater than the cycling exercise 
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used in the Kojima et al. (2015) study. Again, the differences in active muscle mass may 
have affected participants perceptions of appetite. 
Energy intake 
Crabtree & Blannin (2015) and Wasse et al. (2013) investigated the effect of exercise in the 
cold on energy intake. Both studies detected a significant increase in EI following exercise in 
the cold compared to exercise in a neutral environmental temperature, this increase was only 
significant in the Crabtree & Blannin (2015) study. This may be due to differences in the 
populations observed in each study, Crabtree & Blannin (2015) examined overweight men 
and women, while Wasse et al. (2013) studied normal weight males. There were also some 
slight differences in study design, Crabtree & Blannin (2015) used a cold temperature of 8°C 
and a 45-minute treadmill walk at 60% ?̇?O2max, while Wasse et al. (2013) used a similar 
design with a 10°C cold temperature and a 60-minute treadmill run at 65% ?̇?O2max. The lower 
temperature used by Crabtree & Blannin (2015) may have increased individuals EE beyond 
the increase caused by exercise, through a further increase in basal metabolic rate, causing an 
increase in EI. 
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Table 3: Combined effect of environmental temperature and exercise on gut hormones, appetite and energy intake. 
Author Participants Conditions Energy Intake Ghrelin PYY Hunger 
   Absolute Relative Total Acylated   
Faure et al. 
(2016) 
10 healthy 
males 
 
HEAT - 40 
min cycling 
at 60% 
?̇?O2max in 
31°C 
CON - 40 
min cycling 
at 60% 
?̇?O2max in 
22°C 
HEAT = 
1090 ± 296 
CON = 1156 
± 236 (kcal) 
No difference 
between 
HEAT and 
CON 
No difference 
between 
HEAT and 
CON 
NR NR 
No difference 
between 
HEAT and 
CON 
Crabtree & 
Blannin 
(2015) 
16 
overweight 
men and 
women 
 
COLD - 45 
min treadmill 
walk at 60% 
?̇?O2max in 8°C 
CON - 45 
min treadmill 
walk at 60% 
?̇?O2max in 
20°C 
 
COLD = 
1299 ± 657 * 
CON = 1172 
± 537 (kcal) 
COLD = 
1001 ± 664 
CON = 846 ± 
518 
No difference 
between 
COLD and 
CON 
COLD = 1.1 
± 3 
CON = 0.9 ± 
2 (pg/ml) * 
No difference 
between 
COLD and 
CON 
NR 
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Kojima et al. 
(2015) 
11 healthy 
males 
 
COLD - 45 
min cycling 
at 65% 
?̇?O2max in 
12°C 
CON - 45 
min cycling 
at 65% 
?̇?O2max in 
24°C 
HEAT - 45 
min cycling 
at 65% 
?̇?O2max in 
36°C 
 
NR NR NR 
No difference 
between 
COLD, CON 
and HEAT 
No difference 
between 
COLD, CON 
and HEAT 
COLD = 67 ± 
5 
CON = 45 ± 
6 
HEAT = 49 ± 
45 ± 9 (mm) 
* 
Wasse et al. 
(2013) 
11 healthy 
males 
10 healthy 
males 
COLD - 60 
min treadmill 
run at 65% 
?̇?O2max in 
10°C 
CON - 60 
min treadmill 
run at 65% 
?̇?O2max in 
20°C 
HEAT - 60 
min treadmill 
run at 65% 
?̇?O2max in 
30°C 
COLD = + 
347 ± 560 
from CON 
(kcal)  
HEAT = - 
335 ± 574 
from CON 
(kcal)  
NR NR 
No difference 
between 
COLD, CON 
and HEAT 
NR 
Lower in 
COLD and 
HEAT than 
CON 
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Shorten et al. 
(2009) 
11 healthy 
males 
 
CON - 40 
min treadmill 
run at 70% 
?̇?O2max in 
25°C 
HEAT - 40 
min treadmill 
run at 70% 
?̇?O2max in 
36°C 
 
CON = 1194 
± 493 
HEAT = 994 
± 459 (kcal) 
No difference 
between 
CON and 
HEAT 
NR 
No difference 
between 
CON and 
HEAT 
No difference 
between 
CON and 
HEAT 
NR 
* indicates statistical significance (p < 0.05) exact figures stated when reported, relative energy intake calculated as energy intake minus energy expenditure, NR – not 
reported 
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Summary 
A clear understanding of the role of exercise and environmental temperature on 
appetite could enhance current physical activity programmes and recommendations 
for weight control. The general consensus of the current literature is that although 
exercise reduces appetite and EI, and individuals resting in the cold do not increase EI 
to compensate for an increase in EE, the manipulation of environmental temperature 
does not seem to reduce EI to a greater extent than exercise in a neutral temperature. 
However, no study to date has compared the effect of exercise under heat stress, cold 
and thermoneutral conditions to a resting control. This lack of a control trial could 
explain why some studies did not report differences in perceived appetite, EI and gut 
hormones. Comparing trials back to a control trial may prove that exercise reduces 
appetite, and provide new recommendations for weight control if manipulating 
environmental temperature does augment the appetite reducing effect of exercise. 
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METHODS 
 
Participants 
Eleven participants volunteered to take part in this study, three participants did not 
complete the study, the final sample was eight male participants. Participants 
ethnicities were not recorded. All participants were regularly involved in physical 
activity (competitive sport, running, resistance exercise) (table 4). 
Table 4: Participant characteristics 
Characteristic Mean ± SD 
Age (years) 23.1 ± 4.4 
Height (m) 1.79 ± 0.07 
Body mass (kg) 80.9 ± 11.0 
Body fat (%) 18.2 ± 4.8 
Body mass index (kg.m2) 25.4 ± 3.4 
?̇?O2max (mL.kg-1.min-1) 51 ± 9 
?̇?O2max = maximum rate of oxygen consumption 
Prior to participation, participants completed an Informed Consent Form (Appendix 
A), Physical Activity Readiness Questionnaire (PAR-Q) (Appendix B), a Pre-test 
Medical Questionnaire (Appendix C), Blood Screening Form (Appendix D), 
Breakfast Habits Questionnaire (Appendix E) and a Three-Factor Eating 
Questionnaire to assess for abnormal eating habits (Appendix F) (Karlsson et al., 
2000). 18 questions were rated on a four point scale from definitely true (4) to 
definitively false (1), with six questions examining cognitive restraint, nine examining 
unrestrained eating and three examining emotional eating. Participants scoring greater 
than 11 were considered to be exhibiting signs of abnormal eating behaviours and 
were excluded from the study (Stunkard & Messick, 1985). Participants also 
completed a 1-9 rating scale for foods included in each meal used for the experimental 
conditions (Appendix G), participants that did not rate at least one bread or cereal as a 
5 or above (meal 1) or did not rate the pasta meal as 5 or above (meal 2) were 
excluded from the study to avoid differences resulting from participants disliking a 
large proportion of the provided foods. Participants were informed of their right to 
withdraw from the study without question at any time. Ethical approval for this study 
was gained from the University of Bedfordshire Ethics Committee (approval number: 
2016ISPAR010, Appendix J). 
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Preliminary measurements  
The participants' standing height to the nearest 0.01 m (Stadiometer, Holtain Ltd., 
Pembrokeshire, United Kingdom), body mass to the nearest 0.1 kg (BWB0800, Allied 
Weighing, Amsterdam, Netherlands) and body fat percentage to the nearest 0.1% 
(Bod Pod 2000A, Life Measurement, Concord, CA., USA) were measured. 
Participants then completed a sub-maximal exercise test on a motorised treadmill 
(PPS55 Med-I, Woodway, Waukesha, WI., USA). This protocol consisted of four, 4-
minute stages of increasing intensity ranging from 30-80% of maximal oxygen uptake 
(?̇?O2max) at a 1% gradient to reflect energetic costs of outdoor running (Jones & 
Doust, 1996). After a 10-minute rest, participants completed a graded maximal 
exercise test. The test was performed on a motorised treadmill, beginning at a speed 
equating to a heart rate (HR) of ~160 beats·min-1 in the submaximal test and a 0% 
gradient. Speed remained constant throughout the protocol while gradient increased 
by 1% every minute until volitional exhaustion. Expired gas was analysed 
continuously using breath-by-breath online gas analysis for both exercise tests 
(MetaLyzer 3B, Cortex, Leipzig, Germany). Values of oxygen consumption (?̇?O2), 
carbon dioxide production (?̇?CO2) and respiratory exchange ratio (RER) were 
collected and averaged with HR and rating of perceived exertion (RPE) (Borg, 1970) 
in the final 60 seconds of each stage in the submaximal test and in the final 30 
seconds of each stage of the graded maximal exercise test. ?̇?O2max was determined 
using a 30 second rolling average and was deemed to have been achieved when ?̇?O2 
(mL.kg-1.min-1) increased by less than 2 mL.kg-1.min-1 in any stage, or when 2 of the 
following 3 criteria were met; HR within 10 bpm of predicted HRmax, RER above 1.05 
or RPE greater than 19 (ACSM, 2013). Linear regression was used to estimate the 
treadmill speed corresponding to 60% ?̇?O2max for the experimental conditions. 
Experimental design  
For the experimental conditions, participants arrived at the University of Bedfordshire 
Sport and Exercise Science Laboratories at 08:30 after a 12 h fast. All experimental 
conditions were completed in a custom built environmental chamber (T.I.S. Services, 
Hampshire, UK) in 50% relative humidity (RH). The experimental conditions were: 
exercise in the heat (30°C, EX30), exercise in a thermoneutral environment (20°C, 
EX20), exercise in the cold (10°C, EX10), and resting control (20°C, CON) (Figure 
1). Participants were instructed to refrain from consuming caffeine or alcohol and 
participating in strenuous physical activity for 24 hours prior to arrival for 
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experimental conditions. Participants completed a weighed food diary (Appendix H) 
for the 24 hours preceding the initial experimental condition and were asked to 
replicate their diet in the 24 h before all subsequent visits. Participants wore the same 
clothing (t-shirt and shorts) for all conditions. 
 
Figure 1: Schematic representation of the study design. 
The participant’s urine osmolality was measured (Osmocheck, Vitech Scientific, West 
Sussex, United Kingdom) on arrival to ensure a euhydrated state (< 700 mOsmol/kg 
H2O) (ACSM, 1996) Once a euhydrated state was confirmed, participants inserted a 
rectal thermistor (400H, Yellow Springs Instruments, Yellow Springs, OH., USA) 10 
cm past the anal sphincter for measurement of core temperature (Tcore); HR was 
monitored during the insertion to ensure participants safety. Skin thermistors (Eltek 
Squirrel Data, Eltek, Cambridge, UK) were placed at four sites on the left of the body 
(tricep – Tarm, pectoralis major - Tchest, rectus femoris - Tthigh, gastrocnemius - Tcalf) 
and secured with hypafix tape for measurement of skin temperature (Tskin). Weighted 
mean skin temperature (MST) was calculated using the following equation 
(Ramanathan, 1964): 
MST = 0.3 × (Tarm + Tchest) + 0.2 × (Tthigh + Tcalf) 
Mean body temperature (MBT) was calculated at rest using the equation (Livingstone, 
1968): 
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MBT = 0.65 × Tcore + 0.35 × MST 
MBT was calculated during exercise using the equation: 
MBT = 0.8 × Tcore + 0.2 × MST 
The participants HR, thermal sensation, skin and core temperatures were measured 
every 10 minutes throughout each condition.  
A cannula was inserted into an antecubital vein, blood samples of 10 ml were 
collected at 0, 1, 1.5, 2, 3, 4 and 5 hr into vacutainers pre-treated with Ethylene Di-
amine Tetra Acetic acid (EDTA) (BD, Oxford, UK). Perceptions of hunger, satiation, 
fullness and prospective food consumption were assessed using 100 mm visual 
analogue scales (VAS) at 0, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5 and 5 hr. These perceptions of 
appetite were also averaged to give an overall appetite rating after inverting the values 
for satiation and hunger (Stubbs et al., 2000). 
Following fasted measures (0 hr), participants entered the environmental chamber and 
completed one of four conditions. In the exercise conditions (EX10, EX20, EX30) 
participants completed a 60-minute run on a motorised treadmill (PPS55 Med-I, 
Woodway, Waukesha, WI., USA) at 60% ?̇?O2max; in the control condition (CON) 
participants were seated for 60 minutes. Energy expenditure and substrate oxidation 
were estimated using breath-by-breath online gas analysis (MetaLyzer 3B, Cortex, 
Leipzig, Germany) and indirect calorimetry (Frayn, 1983) at 5-10 minutes, 30-35 
minutes and 55-60 minutes of each 60 min condition. During this initial hour, 
participants’ HR, RPE, thermal sensation, skin and core temperatures were measured 
every five minutes. Resting measures were collected with participants in a seated 
position.  
Ad libitum meals were provided at 1.5 and 5 hours. Food quantities were presented in 
excess of expected consumption and were of a precisely known quantity and 
macronutrient composition. Participants had 30 minutes to consume each meal. Meal 
1 was a buffet-type breakfast meal consisting of two types of breakfast cereal, white 
and brown bread, jam, butter, apples, bananas, orange juice and semi-skimmed milk. 
Meal 2 consisted of 500g of pasta (uncooked) and tomato sauce (500g) cooked and 
prepared per manufacturer’s specifications. Meals were presented in an identical 
manner for each condition. Energy intake was offset against EE to give a relative 
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energy intake (REI). Participants were able to consume water ad libitum throughout 
each condition; total water consumption was recorded. 
Blood collection and analysis 
Two 60 µL blood samples were collected from coated EDTA vacutainers into 
heparinised microhematocrit capillary tubes (Heinz Herenz, Hamburg, Germany) and 
spun in a micro centrifuge (Haematospin 1300, Hawksley, Staines, UK) for 2 minutes 
before haematocrit was determined (Reader, Hawksley, Staines, UK). One 10 µL 
sample was collected into a microcuvette (Hb 201, HemoCue, Ängelholm, Sweden) 
for determination of haemoglobin concentration (Hb 201 DM System, HemoCue, 
Ängelholm, Sweden).  
Following determination of haematocrit and haemoglobin concentrations, one 
vacutainer was spun immediately at 1500 g for 10 minutes at 4°C (Heraeus Multifuge 
X3R, Thermo Scientific, Loughborough, UK). The plasma supernatant was separated 
and placed into two cryovials and stored at -80°C until analysis of total PYY. To 
prevent degradation of acylated ghrelin, the remaining filled vacutainer was treated 
with a solution of 50% P-hydroxymercuribenzoic acid (PHMB), 49.4% potassium 
phosphate buffer (PBS) and 0.6% sodium hydroxide (NaOH) in a ratio of 10 µL per 1 
ml of blood and spun at 1500 g for 10 minutes at 4°C. The plasma supernatant was 
separated and treated with 100 µL of hydrochloric acid (HCl) per 1 ml of plasma 
before being spun at 1500 g for 5 minutes at 4°C (Hosoda et al., 2004). The plasma 
was then placed into two separate cryovials and stored at   -80°C until analysis of 
plasma acylated ghrelin. Gut hormone concentrations were analysed using 
commercially available enzyme-linked immunosorbent assay (ELISA), samples from 
each participant were analysed in the same run to avoid intra-assay variation. Inter-
assay variation for PYY was 6.1% - 6.9% (Human PYY (Total) ELISA, Merck, 
Darmstadt, Germany) and was 5.9% - 10.9% for acylated ghrelin (Acylated Ghrelin 
(human) Express ELISA kit, Bertin Pharma, Paris, France). Due to problems with 
blood sampling, acylated ghrelin and plasma YY concentrations are presented as n = 
6. Specifically, participants felt nervous and anxious with regard to the insertion of 
the cannula, the decision was therefore taken in those instances not to continue with 
blood sampling in the consideration for the well-being of the participant and to avoid 
confounding other outcome measures. Intra-assay coefficient of variation was 6.62% 
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and 3.59% for PYY Plates 1 and 2 respectively, and 3.48% and 6.98% for acylated 
ghrelin plates 1 and 2 respectively. 
Statistical analyses 
Statistical analyses were performed using IBM SPSS Statistics 23 (SPSS Inc., 
Chicago, IL., United States). Data are presented as mean ± SD. Significance was 
accepted at an alpha level (type 1 error rate) of 0.05. Normality was assessed using a 
Shapiro-Wilk test. Environmental temperature was separated into hours 0-1 (exercise) 
and hours 1-5 (rest) for analysis. Two-way repeated measures analysis of variance 
(ANOVA) were used to detect significant effects of condition (4), time (11 for mean 
body temperature, 7 & 9 for environmental temperature, 2 for EI, 6 for gut hormones 
or 11 for perceived appetite) and condition  time interactions, with Greenhouse-
Geisser correction applied where sphericity was violated. Area under the curve (AUC) 
was calculated for perceptions of hunger, satiation, fullness, PFC and overall appetite. 
Incremental area under the curve (iAUC) was calculated for plasma PYY and plasma 
acylated ghrelin. One-way analysis of variance was used to identify significant effects 
of condition on AUC and iAUC variables, ?̇?O2, % of ?̇?O2max, EE and water 
consumed. The location of main effects was followed up using Bonferroni correction. 
Where a significant effect of condition and a significant condition  time interaction 
was detected, paired-samples t-tests were used to identify differences between the 
individual conditions at each individual time point. Where a significant effect of time 
and a significant condition  time interaction was detected, paired-samples t-tests 
were used to identify specific changes over time within each individual condition. 
Pearson’s correlation was used to examine correlations between gut hormones and 
overall appetite. 
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RESULTS 
 
Environmental temperature 
Environmental temperature during the exercise bout (0-1 h) in each trial differed 
significantly (p < 0.05) between CON (20.3 ± 0.4°C), EX10 (11.1 ± 1.8°C), EX20 
(20.4 ± 1.0°C) and EX30 (29.2 ± 0.9°C). Post-hoc analyses using Bonferroni 
correction confirmed that environmental temperature was higher in EX30 compared 
with EX20 (p < 0.001), EX10 (p < 0.001) and CON (p < 0.001) and lower in EX10 
compared with EX20 (p < 0.001) and CON (p < 0.001). Environmental temperature at 
rest during hours 1-5 did not differ significantly (p > 0.065) between the conditions 
(CON: 20.3 ± 0.4°C, EX10: 20.4 ± 0.4°C, EX20: 20.5 ± 0.6°C, EX30: 21.0 ± 0.4°C). 
 
Exercise characteristics 
The participants mean responses to exercise are presented in Table 5. 
Table 5: Mean response to exercise in each condition. 
 CON EX10 EX20 EX30 
?̇?O2 (L.min-1) 0.28 ± 0.07 * 2.53 ± 0.39 2.41 ± 0.44 2.46 ± 0.45 
% of ?̇?O2max 7 ± 2 * 63 ± 11 60 ± 11 61 ± 09 
EE (kJ.hour-1) 356 ± 88 * 3427 ± 527 3381 ± 634 3259 ± 498 
Water consumed (mL) 638 ± 308 824 ± 412 689 ± 488 855 ± 341 
* = significantly lower than EX10, EX20 and EX30 (p < 0.001) 
 
Thermoregulation 
Participants’ MBT was significantly affected by condition (F 3,18 = 15.133, p < 0.001), 
time (F 10,60= 33.866, p < 0.001) and there was a condition  time interaction (F 30,180 
= 14.048, p < 0.001). Mean body temperature was significantly greater in EX30 
(35.45 ± 0.11°C) than both CON (34.51 ± 0.19°C) (p = 0.007) and EX10 (34.92 ± 
0.13°C) (p = 0.01). Participants’ MBT was significantly greater in EX30 than CON (p 
< 0.019) from hours 0-2. MBT was also significantly greater in EX20 than CON (p < 
0.025) between hours 0 and 1.5. MBT was greater in EX30 than EX20 (p < 0.024) in 
hours 0.5-1 and greater in EX30 than EX10 (p < 0.035) in hours 1-2. 
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Figure 2: Mean Body Temperature measured over all conditions. Black box = exercise bout and hashed 
box = test meal. * = statistical significant difference from baseline over time in CON (p < 0.033). * = 
statistical significant difference from baseline over time in CON (p < 0.004). * = statistical significant 
difference from baseline over time in CON (p < 0.043). * = statistical significant difference from 
baseline over time in CON (p < 0.007). 
 
Energy intake 
There was no significant main effect for condition (F 3,21 = 1.734, p = 0.191) on EI. 
There was a significant main effect for time (F 1,7 = 7.574, p = 0.028), but no 
significant condition  time interaction (F 3,21 = 0.742, p = 0.539). Energy intake was 
significantly lower (p = 0.028) in meal 1 (4368 ± 448 kJ) than in meal 2 (5347 ± 628 
kJ). Relative energy intake was affected significantly by condition (F 3,21 = 14.462, p 
< 0.001). Relative energy intake was significantly lower in EX10 (5795 ± 2289 kJ) (p 
= 0.005), EX20 (6635 ± 3138 kJ) (p = 0.028) and EX30 (6648 ± 3151 kJ) (p = 0.027) 
when compared with CON (9870 ± 3280 kJ). There were no significant differences in 
macronutrient selection between conditions in meal 1 (p > 0.055).  
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Figure 3: Relative Energy Intake between conditions for both meals. * = statistical significance from 
CON. 
 
Table 6: Total energy intake, relative energy intake and percentage of total 
macronutrient intake of carbohydrate, fat and protein in meal 1 across 4 conditions. 
 CON EX10 EX20 EX30 
Total energy intake (kJ) 
10226 ± 
3343 
8950 ± 2293 9937 ± 3259 9753 ± 3347 
Relative energy intake 
(kJ) 
9870 ± 3280 5795 ± 2289 6635 ± 3138 6648 ± 3151 
Carbohydrate intake (%) 72 ± 3 73 ± 3 75 ± 5 78 ± 6 
Fat intake (%) 12 ± 3 15 ± 3 13 ± 5 11 ± 4 
Protein intake (%) 16 ± 2 12 ± 3 12 ± 2 11 ± 3 
 
 
Gut hormones 
Peptide YY 
There was no significant effect of condition on Δ PYY (F 3,15 = 1.064, p = 0.394). 
There was a significant main effect for time in Δ PYY (F 5,25 = 3.903, p = 0.009). 
There was no significant condition  time effect for Δ PYY (F 15,75 = 1.205, p = 
0.287). Post-hoc analysis did not identify any specific changes over time. There was 
no significant main effect of condition for PYY iAUC (F 3,15 = 1.065, p = 0.393). 
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Figure 4: Δ PYY concentrations from baseline in all conditions. Values are mean ± SD. Black box = 
exercise bout and hashed box = test meal.  
Acylated ghrelin 
There was no significant effect of condition on Δ acylated ghrelin (F 3,15 = 1.179, p = 
0.351). There was a significant main effect for time (F 5,25 = 9.869, p < 0.001) and a 
significant condition  time (F 15,75 = 2.104, p = 0.019) effect for Δ acylated ghrelin. 
Differences in Δ acylated ghrelin over time from baseline for each individual 
condition were identified using paired-samples t-tests, and are shown in Figure 5 a-d.  
Specifically, although Δ acylated ghrelin changed over time from baseline during 
CON, EX10 and EX20, no significant differences were found for EX30. In CON, Δ 
acylated ghrelin was lower at 3 h compared to 0 h only, in EX10 and EX20 Δ acylated 
ghrelin was suppressed at hours 2 and 3 compared to baseline. There was no 
significant effect of condition for acylated ghrelin iAUC (F 3,15 = 0.731, p = 0.549). 
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Figure 5a: Δ acylated ghrelin concentrations from baseline in CON. Black box = exercise bout and 
hashed box = test meal. * = statistically significant change from 0 (p < 0.05). 
 
 
Figure 5b: Δ acylated ghrelin concentrations from baseline in EX10. Black box = exercise bout and 
hashed box = test meal. * = statistically significant change from 0 (p < 0.05). 
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Figure 5c: Δ acylated ghrelin concentrations from baseline in EX20. Black box = exercise bout and 
hashed box = test meal. * = statistically significant change from 0 (p < 0.05). 
 
 
Figure 5d: Δ acylated ghrelin concentrations from baseline in EX30. Black box = exercise bout and 
hashed box = test meal. 
 
Perceptions of appetite 
There were no main effects of condition for hunger, satiation, fullness, PFC or overall 
appetite (p > 0.254). There was a significant effect of time on hunger, satiation, 
fullness, PFC and overall appetite (p < 0.001). There were no significant condition  
time interactions in hunger, satiation, fullness, PFC or overall appetite (p > 0.636). 
Significant changes in overall appetite over time are detailed in Figure 9. Overall 
appetite increased significantly at hour 1.5 and decreased significantly at hour 2. 
Overall appetite remained suppressed significantly until hour 4. There were no 
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significant differences in AUC for hunger, satiation, fullness, PFC or overall appetite 
between conditions (p > 0.281).  
 
Figure 6: Overall appetite in all conditions. Black box = exercise bout and hashed box = test meal. * = 
significant difference for time from hour 0. 
 
Correlations 
There was a significant positive relationship between absolute PYY and overall 
appetite in EX20 at hours 3 (r = 0.823, p = 0.044) and 5 (r = 0.897, p = 0.015). There 
was also a significant positive relationship between absolute acylated ghrelin and 
overall appetite in EX20 at hour 1 (r = 0.837, p = 0.038) and a significant negative 
relationship between absolute acylated ghrelin and overall appetite in EX30 at hour 5 
(r = - 0.832, p = 0.4). 
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DISCUSSION 
 
This is the first study to compare exercise in the heat, cold and neutral conditions to a 
resting control. The aim was to investigate the effect of exercise in heat exposure and 
cold conditions on perceptions of appetite, gut hormones and energy intake. The main 
findings concur with the findings of previous research that exercise reduces REI. 
However, regarding the effects of environmental temperature, this study detected 
findings inconsistent with those of previous research. The addition of exercise and the 
manipulation of environmental temperature did not alter plasma PYY compared to 
rest. Plasma acylated ghrelin responded similarly in all conditions, however, the 
addition of heat produced a blunted response to exercise.  
 
Energy intake 
Total energy intake 
This study did not detect any significant differences in total energy intake between 
conditions. This is in accordance with the finding of minimal meaningful changes in 
plasma acylated ghrelin, plasma PYY and feelings of appetite between the conditions. 
These findings differ from those of previous studies, which generally detected lower 
EI after exercise in the heat (Faure et al., 2016, Wasse et al., 2013, Shorten et al., 
2009) and greater EI after exercise in the cold (Crabtree & Blannin, 2015, Wasse et 
al., 2013). The differences described may be due to differences in experimental 
temperature, exercise mode and intensity or participant characteristics. This study also 
detected a significant effect of time on EI, EI in meal 1 was significantly lower than 
EI in meal 2. This may reinforce the theory that exercise produces a transient 
suppression of appetite, although there were no differences when compared with the 
resting control condition. Other studies that did detect significant differences in EI 
offered a wider range of food for consumption at a buffet meal (Kojima et al., 2016). 
This wider variety may have allowed participants to select different macronutrients in 
response to exercise in different environmental temperatures. However, a wider 
variety of available food may also have encouraged over-eating (Blundell et al., 
2010).  
As there was no significant difference in EI between exercise and rest conditions in 
this study, it can be said that exercise had no significant effect on EI regardless of 
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environmental temperature. Studies by Kojima et al. (2016) and Ueda et al. (2009a) 
both detected significant decreases in EI after exercise compared to rest in 
thermoneutral conditions. Unlike the present study, Kojima et al. (2016) did detect a 
significant decrease in EI after aerobic exercise compared to a resting control, 
however the exercise protocol in that study (20 km outdoor run) was greater in time 
and distance than that used in the present study, proving a likely cause for the 
differences observed between the studies. Ueda et al. (2009a) detected significant 
decreases compared to a resting control following 30 minutes moderate (50% of 
?̇?O2max) and high (75% of ?̇?O2max) intensity cycling exercise. However, Ueda et al. 
(2009a) also provided a test meal to participants prior to exercise, whereas 
participants in the present study exercised in a fasted state. Studies by Shorten et al. 
(2009) and Martins et al. (2007) however, detected increases in EI after exercise 
compared to control, which conflicts with the findings of Kojima et al. (2016) and 
Ueda et al. (2009a). The difference in the findings of Martins et al. (2007) and this 
study may be that EE in that study was not sufficient to supress appetite. Energy 
expenditure from a 1 hour treadmill run at 61% of ?̇?O2max in this study was 3381 ± 
634 kJ compared to 2059 ± 385 kJ from 1 hour cycling at 65% HRmax in the Martins 
et al. (2007) study. Shorten et al. (2009) also detected a significant increase in EI 
compared to a resting control after a 40-minute run at 72% of ?̇?O2max expending 2375 
± 280 kJ. This raises the question of a possible EE, or exercise intensity threshold that 
must be achieved in order to supress appetite. 
As with past research, this study did not find any difference in EI between exercise in 
the heat and exercise in a neutral temperature (Faure et al., 2016, Wasse et al., 2013, 
Shorten et al., 2009). With regard to exercise in the cold, this study concurs with 
Wasse et al. (2013) in finding no significant difference in EI after exercise in the cold 
compared to exercise in a neutral environmental temperature. However, Crabtree & 
Blannin (2015) report a significant increase in EI after exercise in the cold compared 
to a neutral environmental temperature, although these differences may be explained 
by differences in population and study design. Firstly, Crabtree & Blannin (2015) 
studied an overweight population; as previously stated, overweight individuals have 
been shown to have higher circulating levels of plasma acylated ghrelin than their 
normal weight counterparts (Ueda et al., 2009b). This may, in turn, increase appetite 
and EI.  
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Overall, the present study suggests that for exercise in the heat to have a significant 
effect on perceived appetite, the temperature may need to exceed 30°C and may need 
to be at least 36°C, as this temperature showed a significant decrease in perceived 
appetite from a neutral temperature in the study conducted by Kojima et al. (2015). 
Relative energy intake 
In agreement with previous research, REI was lower during the exercise conditions 
compared with the resting control in the present study (Kojima et al., 2016, Douglas 
et al., 2015, Larson-Meyer et al., 2012, King et al., 2010, Martins et al., 2007). 
However, the environmental temperature in which the exercise was performed did not 
influence REI. These findings replicate those other studies, reporting no difference in 
REI when comparing exercise in the heat, cold and thermoneutral conditions (Faure et 
al., 2016, Crabtree & Blannin, 2015, Shorten et al., 2009). These studies suggest that 
exercise suppresses REI regardless of environmental temperature. This reduction in 
REI is due to the EE from exercise, as EI was unaffected.  
 
Perceptions of appetite 
This study detected no significant differences between conditions, this is in contrast to 
previous research showing exercise produces a transient decrease in perceptions of 
appetite.  The findings of this study contrast with findings by Wasse et al. (2013), 
detecting a trend for lower overall feelings of hunger post-exercise (hours 1 and 1.5) 
in the heat, cold and thermoneutral conditions compared to control, although this was 
not associated with a decrease in EI. There was no difference in the response of 
perceived appetite to exercise in the cold and the heat in this study. This lack of 
difference in overall appetite is reinforced by the lack of change in plasma PYY and 
acylated ghrelin, suggesting no physiological stimulation for a change in appetite. 
The change in environmental temperature in this study caused a little to no change in 
perceived appetite, and did not have the suppressive effect seen in other research 
(Kojima et al., 2015, Wasse et al., 2013). This may be due to the differences in 
experimental environmental temperature, as the ‘hot’ temperature in this study was 
lower than that utilised by Kojima et al. (2015) (36°C). 
It is possible that in the present study, exercise intensity was not great enough to 
stimulate a decrease in plasma acylated ghrelin or an increase in plasma PYY to 
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reduce appetite. Exercise intensities of 70% of ?̇?O2max have been shown to stimulate 
an increase in plasma PYY (Broom et al., 2009) and a decrease in plasma acylated 
ghrelin (Larson-Meyer et al., 2012). However, exercise at 70% of ?̇?O2max may not be 
feasible for the target population of overweight and obese individuals. 
 
Gut hormones 
Peptide YY 
This study found no significant changes in PYY over time or between conditions, 
these findings agree with those of some previous research reporting no increase in 
plasma PYY in response to an acute bout of aerobic exercise in neutral environmental 
temperatures compared to a resting control (Kojima et al., 2016, Douglas et al., 2015, 
Larson-Meyer et al., 2012, Shorten et al., 2009). However, some studies have 
produced findings in conflict, reporting an increase in plasma PYY after exercise in a 
neutral temperature compared to a resting control (Broom et al., 2009, Ueda et al., 
2009a, Martins et al., 2007). Of those studies, the study with an exercise protocol 
most closely resembling that of the present study (60-minute treadmill run at 61% of 
?̇?O2max) was conducted by Broom et al. (2009) (60-minute run at 70% of ?̇?O2max). the 
difference in plasma PYY observed between these studies is likely due to the lower 
intensity exercise in the present study. This suggests that there may be an exercise 
intensity threshold that must be reached in order to affect appetite through a 
suppression of plasma PYY. Ueda et al. (2009a) also detected a significant increase in 
plasma PYY after 30 minutes cycling at 50 or 75% of ?̇?O2max compared to rest. As 
that study used two different exercise intensities, one lesser and one greater than that 
used in this study, the differences observed are not likely due to exercise intensity. It 
may be that the test meal provided to participants by Ueda et al. (2009a) is 
responsible for the differences observed, those participants would have their gastric 
emptying slowed by exercise, this greater stomach fill increases the stimulation of 
PYY secretion. This may also be the cause of the increase in plasma PYY observed 
by Martins et al. (2007) following a 60-minute cycle at 65% maxHR compared to 
rest. 
Kojima et al. (2016) observed no significant changes in plasma PYY following a 20 
km (78 minutes) run compared to a resting control condition. The differences 
observed between this study and that conducted by Kojima et al. (2016) may have 
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been due to the population, Kojima et al. (2016) used a sample of male endurance 
runners, training for 2.5 hours six times a week. As the effects of prolonged aerobic 
exercise on plasma PYY have not been investigated, it is possible that the high 
training workload had the effect of blunting these individuals’ plasma PYY response. 
Plasma PYY did not increase significantly compared to a resting control in response 
to a 40-minute treadmill run at 70% of ?̇?O2max in a study by Shorten et al. (2009). The 
exercise duration is the main difference between the present study and Shorten et al. 
(2009), this is a possible reason for the discrepancies observed between the two 
studies as shorter duration exercise has previously been shown to have a lesser effect 
of plasma PYY (Ueda et al., 2009a, Martins et al., 2007). 
The addition of manipulation of environmental temperature to exercise also did not 
have an effect on plasma PYY. Exercise in the heat and the cold did not result in a 
change in plasma PYY concentrations compared to rest or exercise in a thermoneutral 
environment. These findings are the same as those of Crabtree & Blannin (2015) and 
Kojima et al. (2015) finding no difference in plasma PYY after exercise in the cold 
compared to a neutral temperature. Furthermore, Kojima et al. (2015) and Shorten et 
al. (2009) also did not detect a difference in plasma PYY after exercise in the heat 
compared to exercise in a neutral temperature. 
Acylated ghrelin 
This study also produced findings in conflict with those of other studies investigating 
the effects of exercise in different environmental temperatures on acylated ghrelin, 
detecting significant change in acylated ghrelin over time (Crabtree & Blannin, 2015, 
Kojima et al., 2015, Wasse et al., 2013, Shorten et al., 2009). In a neutral 
temperature, plasma acylated ghrelin trended to follow previous literature and was 
suppressed as a result of aerobic exercise (Larson-Meyer et al., 2012, King et al., 
2010, Broom et al., 2009, Broom et al., 2007). However, there were also several 
studies producing contradictory findings to the present study (Douglas et al., 2015, 
Kojima et al., 2015, Broom et al., 2009, Shorten et al., 2009). Of those studies, 
Douglas et al. (2015) did not measure plasma acylated ghrelin at similar time points 
to the present study and is therefore not directly applicable for comparison. Following 
a 40-minute run at 70% of ?̇?O2max, Shorten et al. (2009) did not detect any difference 
from baseline or from a resting control. It is possible that the exercise duration in this 
study was not great enough to promote an increase in plasma acylated ghrelin, as only 
exercise durations in excess of 40 minutes has been shown to increase plasma 
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acylated ghrelin (Kojima et al., 2016, Larson-Meyer et al., 2012, King et al., 2010, 
Broom et al., 2007). 
Surprisingly, exercise in the heat and the cold environments did not have the expected 
effect on plasma acylated ghrelin. An increase in environmental temperature blunted 
the exercise related decrease of plasma acylated ghrelin after meal 1, where there was 
a significant decrease in plasma acylated ghrelin in all other trials. This suggests a 
reduction in appetite sensitivity after exercise in the heat. In the cold, plasma acylated 
ghrelin was decreased immediately after exercise, producing findings similar to those 
of Kojima et al. (2015), detecting a transient decrease, in both studies plasma acylated 
ghrelin levels rose to near-baseline 30 minutes after exercise. Wasse et al. (2013) also 
detected a decrease in plasma acylated ghrelin from baseline but no difference 
between cold and thermoneutral conditions after a 60-minute treadmill run at 65% of 
?̇?O2max, although this decrease was also transient and plasma acylated ghrelin rose 
again 60 minutes after exercise. A study by Crabtree & Blannin (2015) reported 
findings in conflict with those of the present study with regard to the response of 
plasma acylated ghrelin to an aerobic exercise bout in the cold. Crabtree & Blannin 
(2015) detected a significant increase in plasma acylated ghrelin following a 45-
minute treadmill walk at 60% of ?̇?O2max. Population differences are a possible cause 
of the difference between the studies, Crabtree & Blannin (2015) studied an 
overweight population versus a normal weight population in the present study. This 
difference was investigated by Ueda et al. (2009b), finding that acylated ghrelin was 
higher in overweight than normal weight individuals at rest and after exercise. This 
may partly explain the differences observed between these studies. 
With regard to the effect of exercise in the heat on plasma acylated ghrelin, this study 
found differences from previous research (Kojima et al., 2015, Wasse et al., 2013, 
Shorten et al., 2009). Plasma acylated ghrelin did not change significantly from 
baseline in this study following exercise in the heat. A study conducted by Kojima et 
al. (2015) detected a significant decrease from baseline in acylated ghrelin following 
exercise in the heat, Wasse et al. (2013) and Shorten et al. (2009) also detected a 
decrease after exercise in the heat, although not significant. It is possible that the 
greater temperature used in the heat condition in the Kojima et al. (2015) study 
(36°C) compared to the present study (29°C) is responsible for the discrepancies in 
the findings. Shorten et al. (2009) report findings dissimilar to the present study, 
detecting a suppression of plasma acylated ghrelin after exercise in the heat, though 
 44 
this was not significant. This is likely due to the difference in environmental 
temperature, Shorten et al. (2009) used a temperature of 36°C to expose individuals to 
heat, compared to 29°C in the present study. Kojima et al. (2015) also detected a 
decrease in plasma acylated ghrelin post-exercise using a temperature of 36°C, 
suggesting the temperature used in the present study was not great enough to promote 
a suppression of plasma acylated ghrelin. 
 
The findings of this study can be explained by the lack of change and difference in the 
gut hormones PYY and acylated ghrelin between conditions, this had the effect of not 
changing perceptions of appetite. As a result of this, there was no difference in the 
stimulus to consume food, causing there to be no difference in EI between conditions. 
 
Limitations 
There were several limitations to the present study. Firstly, the small sample size of 
eight young males may have been insufficient to detect significant differences in gut 
hormones. A post-hoc sample size calculation revealed that a sample size of 12 would 
have been needed to detect a significant difference in plasma acylated ghrelin iAUC 
and plasma PYY iAUC (G*Power, Heinrich Heine University, Düsseldorf, Germany).  
Also, as this study used only male participants it is not possible to expand the findings 
to females, although the responses between males and females are suggested to be 
similar (Alajmi et al., 2016). Furthermore, it is not known if children, adolescents or 
an older population would respond differently to the exercise and environmental 
interventions used in the present study. 
Acylated ghrelin and PYY are not the only gut hormones thought to regulate appetite, 
it has been suggested that the gut hormones pancreatic polypeptide and GLP-1 
suppress appetite (Schubert et al., 2014). Had the present study measured those 
additional gut hormones, it may have been possible to gain a greater understanding of 
the effects of exercise and environmental temperature on appetite. 
The relative discomfort of having a cannula and rectal thermistor inserted may have 
reduced participants desire to eat, reducing relative and total energy intake; this 
discomfort was reported anecdotally by several participants. Other participants 
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reported apprehension and anxiety regarding the insertion of the cannula. Although 
these effects would have occurred in each condition, it is possible that the effect 
would diminish in later visits as participants became accustomed to the discomfort 
and may override the possible intervention effects.  
 
Implications 
This study has reinforced the finding that exercise reduces REI. In addition, the 
finding of this study is that environmental temperature does not limit the REI 
reducing effect of exercise. This is an important finding for an overweight and obese 
population wishing to lose weight, as individuals can be reassured that REI will be 
suppressed regardless of environmental temperature, inducing an energy deficit, 
which will result in weight loss if chronically maintained. 
Athletes and those involved in recreational physical activity should also be wary of 
the effects of exercise on appetite. Individuals should be aware that they will be at an 
energy deficit after exercise, and at risk of unwanted weight loss if a conscious effort 
is not made to account for the reduced EI. 
Individuals entering extremely cold environments (mounting climbing, polar 
exploration) should also be aware of the reduction of REI due to not compensating for 
the increase in EE, resulting in a negative energy balance and weight loss. This is 
particularly important due to the risk to life in those extreme environments.  
This study has provided the suggestion that exercise in the heat blunts the response of 
plasma acylated ghrelin to subsequent meals, reducing appetite sensitivity. This may 
be problematic to those seeking weight loss, as higher acylated ghrelin at the 
termination of a meal may increase EI in the next meal. 
 
Directions for future research 
The effect of repeated exercise sessions on appetite has not been widely investigated. 
This would be an important piece of research, both for athletes and the overweight 
and obese, as it would give an opportunity to produce recommendations on the long-
term effects of recreational exercise or training with regard to changes in EI. 
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It may prove prudent to repeat the present study using an overweight or obese 
population, so as to assess the interventions’ effectiveness in that target population. If 
an effect is shown in that population, a long-term study (> 3 months) may be 
conducted to assess its effectiveness as a weight loss protocol. 
The heat condition in this study did not alter EI or promote a significant increase in 
PYY or decrease in acylated ghrelin using a temperature of 30°C. Other studies have 
detected changes in EI using a temperature of 36°C, suggesting a temperature 
threshold  (Kojima et al., 2015, Shorten et al., 2009). A direct comparison of exercise 
in 30°C and 36°C would aid in identifying a temperature great enough to promote a 
decrease in appetite. 
The exercise in the present study, 61% of ?̇?O2max, may also not have been of great 
enough intensity to produce changes in appetite, where other studies have detected 
reductions in appetite using 70% of ?̇?O2max (Shorten et al., 2009). This decrease from 
other research may be replicated if the present study were replicated using the 
intensity of 70% of ?̇?O2max. 
There is currently very little literature on the differing effects of running and cycling 
on appetite. A single direct comparison suggests running and cycling have similar 
effects on appetite, however this requires further investigation (Wasse et al., 2012). If 
the two modes prove equivalent in the reduction of appetite and energy intake, cycling 
may be a preferable option for the overweight and obese due to the reduced weight 
bearing nature and therefore reduced knee stress. 
Overall, the results in this research area are conflicting, therefore the effects of 
environmental temperature manipulation and exercise on appetite requires further 
clarification in future research.  
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CONCLUSION 
 
This study found that exercise reduced relative energy intake regardless of 
temperature, although this reduction did not correlate with either increases in plasma 
PYY or decreases in plasma acylated ghrelin. This decrease in relative energy intake 
was also not associated with any exercise related decrease in overall appetite. These 
findings are in conflict with those of other studies, which have found a decrease in 
energy intake after exercise in the heat compared with colder temperatures. Due to the 
limited evidence base, further research is required to understand the combined effects 
of exercise and environmental temperature on appetite and EI in a variety of 
populations.   
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APPENDICES 
A - Informed Consent Form 
CONSENT FORM  
TO BE COMPLETED BY PARTICIPANT  
NAME: ………………………………………………… (Participant)  
I have read the Information Sheet concerning this project and understand 
what it is about. All my further questions have been answered to my 
satisfaction. I understand that I am free to request further information at any 
stage.  
I know that:  
• My participation in the project is entirely voluntary and I am free to 
withdraw from the project at any time without disadvantage or 
prejudice.  
• I will be required to attend 5 sessions in the laboratory (1 for 
preliminary measures and 4 for main trials) to complete the project.  
 
As part of the study I will have to:  
• Complete a maximal exercise test for the measurement of VO2max 
• Exercise in a hot (30 °C), cold (10°C), and thermoneutral (20°C) 
environments for 60 minutes 
• Insert a rectal thermometer to measure core temperature  
• Give blood samples to be analysed for a number of hormones 
• Consume ad libitum meals 
 
I am aware of any risks that may be involved with the project.  
All information and data collected will be held securely at the University 
indefinitely. The results of the study may be published but my anonymity will 
be preserved. 
 
 
Signed ………………………………… (Participant) Date: ………………  
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B - Physical Activity Readiness Questionnaire 
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C - Pre-Test Medical Questionnaire 
PRE-TEST MEDICAL QUESTIONNAIRE 
To be completed by all subjects before participating in practical sessions. 
 
Name: ………………………………………………….  
Age:……………   Gender:  M    /    F 
 
1 Are you in good health?      Yes    /    No 
If no, please explain:      
 
2 Are you pregnant or have you given birth in the last 6 months? Yes    /    No 
 
3 How would you  describe  your present level  of  moderate activity? 
 < once per month 
     once per month 
     2-3 times per week 
     4-5  times per week 
  > 5 times per week 
 
4 Have you suffered from a serious illness or accident?   Yes    /    No 
If yes, please give particulars: 
 
5 Are you recovering from an illness or operation?   Yes    /    No 
If yes, please give particulars: 
 
6 Do you suffer, or have you ever suffered from: 
Respiratory conditions (asthma, bronchitis, tuberculosis, other)?  Yes    /    No 
Diabetes?     Yes    /    No 
Epilepsy?     Yes    /    No 
High blood pressure?     Yes    /    No 
Heart conditions or circulation problems: 
(angina, high blood pressure, varicose vein, aneurysm, embolism, heart attack, 
other)?  
Do you have chest pains at any time?     Yes    /    No 
Do you suffer from fainting/blackouts/dizziness?         Yes    /    No 
Is there any history of heart disease in your family?   Yes    /    No 
 
7 Are you currently taking medication ?   Yes    /    No 
If yes, please give particulars: 
 
8 Are you currently attending your GP for any condition or have you consulted your 
doctor in the last three months? If yes, please give particulars:   Yes    /    No  
9 Have you had to consult your doctor, or had hospital treatment within the last six 
months?        Yes    /    No 
 
10 Have you, or are you presently taking part in any other  
laboratory experiment?      Yes    /    No 
 
11. Are you currently fitted with a pacemaker?   Yes    /    No 
 
12. Do you have any food allergies or intolerances?   Yes /   No 
 
If yes, please state what this allergy or intolerance is……………………………… 
 
PLEASE READ THE FOLLOWING CAREFULLY: 
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Persons will be considered unfit to do the experimental exercise task if they: 
have a fever, suffer from fainting spells or dizziness; 
have suspended training due to a joint or muscle injury; 
have a known history of medical disorders, i.e. high blood pressure, heart or 
lung disease;  
have had hyper/hypothermia, heat exhaustion, or any other heat or cold 
disorder; 
have anaphylactic shock symptoms to needles, probes or other medical-type 
equipment.  
have chronic or acute symptoms of gastrointestinal bacterial infections (e.g. 
Dysentery, Salmonella) 
have a history of infectious diseases (e.g. HIV, Hepatitis B); and, if 
appropriate to the study design, have a known history of rectal bleeding, anal 
fissures, haemorrhoids, or any other condition of the rectum; 
 
I have read the statement above and confirm that I am not considered unfit to do 
the experimental exercise task: 
 
Name of subject (please print) ___________________________________________ 
Signature of Subject _____________________________            Date: ___________ 
Name of Experimenter (please print) ______________________________________ 
Signature of Experimenter  _______________________            Date: ____________ 
 
DECLARATION 
I hereby volunteer to be a subject in experiments/investigations during the period of 
20___. 
 
My replies to the above questions are correct to the best of my belief and I 
understand that they will be treated with the strictest confidence. The experimenter 
has explained to my satisfaction the purpose of the experiment and possible risks 
involved. 
 
I understand that I may withdraw from the experiment at any time and that I am under 
no obligation to give reasons for withdrawal or to attend again for experimentation. 
 
Furthermore, if I am a student, I am aware that taking part or not taking part in this 
experiment, will neither be detrimental to, or further my position as a student. 
 
I undertake to obey the laboratory/study regulations and the instructions of the 
experimenter regarding safety, subject only to my right to withdraw declared above. 
 
Name of subject (please print) ___________________________________________ 
Signature of Subject _____________________________            Date: ___________ 
Name of Experimenter (please print) ______________________________________ 
Signature of Experimenter  _______________________            Date: ____________ 
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D - Blood Screening Form 
 
 
 
Please read the following: 
 a. Are you suffering from any known active, serious infection?  
 b. Have you had jaundice within the previous year?  
 c. Have you ever had any form of hepatitis?  
 d. Have you any reason to think you are HIV positive?  
 e. Have you ever been involved in intravenous drug use?  
 f. Are you a haemophiliac? 
 g. Is there any other reason you are aware of why taking blood might 
be   hazardous to your health?  
 h. Is there any other reason you are aware of why taking your blood 
might be  hazardous to the health of the technician? 
Can you answer Yes to any of questions a-g? Please tick your response. 
 
 
 Yes   No 
 
Small samples of your blood (from finger or earlobe) will be taken in the 
manner outlined to you by the qualified laboratory technician. All relevant 
safety procedures will be strictly adhered to during all testing procedures (as 
specified in the Risk Assessment document available for inspection in the 
laboratory). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
I declare that this information is correct, and is for the sole purpose of giving the 
tester guidance as to my suitability for the test.  
 
Signed ………………………………………  
 
Date ………………………………………  
 
If there is any change in the circumstances outlined above, it is your 
responsibility to tell the person administering the test immediately. 
 
BLOOD ANALYSIS – Participant Screening Form 
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E - Breakfast Habits Questionnaire 
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 63 
F - The Three-Factor Eating Questionnaire 
The Three-Factor Eating Questionnaire 
 
Please read each statement and select from the multiple choice options the 
answer that indicates the frequency with which you find yourself feeling or 
experiencing what is being described in the statements below. 
 
1. When I smell a delicious food, I find it very difficult to keep from eating, even if I 
have just finished a meal. 
Definitely true (4)/ mostly true (3)/ mostly false (2)/ definitely false (1) 
 
2. I deliberately take small helpings as a means of controlling my weight. 
Definitely true (4)/ mostly true (3)/ mostly false (2)/ definitely false (1) 
 
3.When I feel anxious, I find myself eating. 
Definitely true (4)/ mostly true (3)/ mostly false (2)/ definitely false (1) 
 
4. Sometimes when I start eating, I just can’t seem to stop. 
Definitely true (4)/ mostly true (3)/ mostly false (2)/ definitely false (1) 
 
5. Being with someone who is eating often makes me hungry enough to eat also. 
Definitely true (4)/ mostly true (3)/ mostly false (2)/ definitely false (1) 
 
6. When I feel blue, I often overeat. 
Definitely true (4)/ mostly true (3)/ mostly false (2)/ definitely false (1) 
 
7. When I see a real delicacy, I often get so hungry that I have to eat right away. 
Definitely true (4)/ mostly true (3)/ mostly false (2)/ definitely false (1) 
 
8. I get so hungry that my stomach often seems like a bottomless pit. 
Definitely true (4)/ mostly true (3)/ mostly false (2)/ definitely false (1) 
 
9. I am always hungry so it is hard for me to stop eating before I finish the food on 
my plate. 
Definitely true (4)/ mostly true (3)/ mostly false (2)/ definitely false (1) 
 
10. When I feel lonely, I console myself by eating. 
Definitely true (4)/ mostly true (3)/ mostly false (2)/ definitely false (1) 
 
11. I consciously hold back at meals in order not to weight gain. 
Definitely true (4)/ mostly true (3)/ mostly false (2)/ definitely false (1) 
 
12. I do not eat some foods because they make me fat. 
Definitely true (4)/ mostly true (3)/ mostly false (2)/ definitely false (1) 
 
13. I am always hungry enough to eat at any time. 
Definitely true (4)/ mostly true (3)/ mostly false (2)/ definitely false (1) 
 
14. How often do you feel hungry? 
Only at meal times (1)/ sometimes between meals (2)/ often between meals (3)/almost 
always (4) 
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15. How frequently do you avoid “stocking up” on tempting foods? 
Almost never (1)/ seldom (2)/ moderately likely (3)/ almost always (4) 
 
 
16. How likely are you to consciously eat less than you want? 
Unlikely (1)/ slightly likely (2)/ moderately likely (3)/ very likely (4) 
 
17. Do you go on eating binges though you are not hungry? 
Never (1)/ rarely (2)/ sometimes (3)/ at least once a week (4) 
 
18. On a scale of 1 to 8, where 1 means no restraint in eating (eating whatever 
you want, whenever you want it ) and 8 means total restraint (constantly limiting 
food intake and never “giving in”), what number would you give yourself? 
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G - Experimental Food Rating Scale 
Please rate the following items honestly 
Breakfast: 
 
Kelloggs Bran Flakes 
(Dislike Extremely) 1   2   3   4   5   6   7   8   9 (Like Extremely) 
 
Weetabix 
(Dislike Extremely) 1   2   3   4   5   6   7   8   9 (Like Extremely) 
 
White Bread 
(Dislike Extremely) 1   2   3   4   5   6   7   8   9 (Like Extremely) 
 
Brown Bread 
(Dislike Extremely) 1   2   3   4   5   6   7   8   9 (Like Extremely) 
 
Strawberry Jam 
(Dislike Extremely) 1   2   3   4   5   6   7   8   9 (Like Extremely) 
 
Butter 
(Dislike Extremely) 1   2   3   4   5   6   7   8   9 (Like Extremely) 
 
Banana 
(Dislike Extremely) 1   2   3   4   5   6   7   8   9 (Like Extremely) 
 
Apple 
(Dislike Extremely) 1   2   3   4   5   6   7   8   9 (Like Extremely) 
 
Semi-Skimmed Milk 
(Dislike Extremely) 1   2   3   4   5   6   7   8   9 (Like Extremely) 
 
Orange Juice 
(Dislike Extremely) 1   2   3   4   5   6   7   8   9 (Like Extremely) 
 
Pasta Meal: 
 
Pasta with Vegetable Tomato Sauce 
(Dislike Extremely) 1   2   3   4   5   6   7   8   9 (Like Extremely) 
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H - Food Diary 
FOOD DIARY INSTRUCTIONS 
 
• Everything that you eat and drink in the 24 h before your first main trial 
should be recorded in this diary and weighed using the digital 
scales provided. 
 
• You will be required to replicate this diet in the 24 h before your 
remaining three main trials, so it important that you only consume 
foods and drinks that you can replicate (for example, do not eat a 
home-cooked meal that someone else has cooked, if you will not be 
able to eat this again before your remaining trials).  
 
• Please make sure you fill in all the columns for each food/drink item:  
 
1. Date and time of day – the date and time you had the 
food/drink (you only need to write the date at the beginning of 
each day).  
2. Brand name – for example, Kelloggs or Heinz. 
3. Description – as much detail as possible. Please tell us the 
manufacturer’s name (e.g. Kelloggs, Heinz) and cooking method 
(e.g. grilled, roast, boiled).  
4. Amount served – This must be the exact weight served in 
grams; most snack foods will have the weight of the food on the 
packet so you can write this in your diary.  
5. Leftovers – This is the amount that you did not eat or drink in 
grams (e.g. apple cores, crusts of bread). 
 
• This information is important for understanding our results from the 
study, so it is very important that you avoid missing things out or 
making it up! Thank you!  
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Date and 
time of 
day 
Brand name 
(e.g. Heinz, 
Tesco, Kel-
logs) 
Detailed description of 
food/drink and cooking 
method 
(e.g. boiled potatoes, 
canned sweetcorn, 
bacon fried in 
sunflower oil) 
Amount served 
(grams) 
Leftovers (grams) 
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I – Participant Information Sheet 
INFORMATION SHEET  
The effect of environmental temperature during exercise on appetite and appetite-
regulatory hormones. 
 
Dear Participant,  
 
Thank you for showing an interest in participating in the study. Please read this 
information sheet carefully before deciding whether to participate. If you decide to 
volunteer, we thank you for your participation. If you decide not to take part, there will be 
no disadvantage to you of any kind and we thank you for considering our request.  
 
What is the aim of the project?  
The purpose of the study is to investigate whether exercise performed in different 
environmental temperatures affects energy intake and appetite-regulatory hormones.  
 
What type of participant is needed?  
Males aged between 18-35 years who are not heat acclimated are eligible to participate 
in the study. A health screen questionnaire must be completed by each individual who 
volunteers to participate in the study. Those with the following conditions may be 
excluded from the study for their own safety: musculoskeletal injury that has affected 
normal movement within the last month, disturbance of vision, congenital heart disease, 
uncontrolled exercise-induced asthma, diabetes, epilepsy and chronic obstructive 
pulmonary disease (COPD). As it is not feasible to list every medical condition, it is 
possible that those with other medical conditions, not given above, may be excluded 
from the study once identified. 
 
What will participants be asked to do?  
Participants will be required to attend the laboratory on five separate occasions. During 
the first visit preliminary measurements will be taken, including height, weight and 
Bodpod to measure body composition. This visit will also include a submaxial 
incremental exercise test and a maximal oxygen uptake (VO2max) test where you will be 
asked to exercise to volitional exhaustion. You will also be familiarised with the 
environmental chamber and range of temperatures in which you will be asked to perform 
exercise during sessions 2-5 (i.e., 10°C, 20°C and 30°C). For sessions 2-5, you will be 
asked to complete the following in the fasted state: 
• 60 minutes of treadmill exercise at 70% VO2max in a thermoneutral (20°C) 
environment 
• 60 minutes of treadmill exercise at 70% VO2max in a cold (10°C) environment 
• 60 minutes of treadmill exercise at 70% VO2max in a hot (30°C) environment 
• Rest for 60 min in a thermoneutral environment 
 
After completing one of the 60 min treatments above, you will be asked to rest in a 
thermoneutral (20°C) environment for 4 hours. Participants will be provided with a two 
ad libitum meals – one at 30 min and the other at 4 h post-treatment. Throughout the 
trials, measures of thermal sensation, blood samples and subjective feelings of hunger and 
temperature will be taken. A rectal thermometer will be used for the measurement of core 
temperature. Please also note that you will be required to record your food and drink 
intake the day before visit 2 and replicate this the day before visits 3, 4 and 5. You will be 
asked to consume a high-carbohydrate meal (e.g., rice- or pasta-based) at approximately 
20:00 h the evening before main trials, as you will be required to exercise for 60 minutes 
in the fasted state the next morning. 
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What are the possible risks of taking part in the study?  
Participants will not be placed under any unnecessary physical or mental stress 
throughout the duration of the study. Potential risks of participating are as follows: 
- Consent – Participants will be informed of the study and what they will be required do. 
A consent form will be completed before test measurements commence.  
- Anonymity – The data collected would not in any way be linked to specific participants. 
Data collected will be either locked in a filing cabinet by a University member of staff or 
either in a password protected folder on a computer. 
- BodPod – During visit 1. claustrophobia may occur when inside the Bodpod. However 
the participant will be made aware of the emergency release button.  
- Blood sampling – Blood samples will be taken by a trained researcher. A certified first 
aider will be on-site whilst blood sampling occurs and all procedures will be given special 
care. Samples will be collected in a clean and sterile environment to avoid the chance of 
infection and all wounds will be treated until bleeding has stopped and then covered to 
reduce the risk of infection. 
- Exposure to extreme heat or cold – Risks associated with extreme heat are 
hyperthermia – this may include muscle cramps, fast pulse and loss of consciousness. 
Risks associated with the cold are hypothermia – this may include shivering, pale skin 
and loss of consciousness. To prevent these symptoms occurring, core temperature will 
be monitored throughout all trials using a rectal thermometer. Please note that there are 
risks associated with of inserting anything into the body can cause shock (e.g., the rectal 
probe); specific safety precautions will be carried out in case of any medical 
emergencies to ensure the participant is safe (e.g., the door will remain unlocked in case 
medical attention is required if the participant suffers anaphylactic shock). 
- Physical stress during exercise - Participants will be informed of the exercise protocol 
and all safety procedures will be explained before testing commences. A safety mat will 
always be present behind the treadmill and clear of any equipment, in order to minimise 
the risk of injury. For the main trials, you will be asked to exercise in the fasted state. It is 
possible that you may experience low blood glucose levels and feelings of dizziness or 
sickness, particularly if you are not used to completing fasted exercise. To minimise the 
risk of low blood glucose, we ask you to consume a high-carbohydrate meal the evening 
before the main trials. We can also provide you with food at the laboratories if needed. A 
first aider will be present at all times within the laboratories. A researcher will be present 
at all times during exercise to ensure participants are not in any discomfort. Exercise will 
be terminated if participants feel ill or are in discomfort or pain. 
 
What if you decide you want to withdraw from the project?  
If, at any stage you wish to leave the project, then you can. There is no problem should 
you wish to stop taking part and it is entirely up to you. There will be no disadvantage to 
yourself should you wish to withdraw.  
 
What will happen to the data and information collected?  
Everyone that participates in the study will receive their own results for the tests that 
they complete. All information and results collected will be held securely at the University 
of Bedfordshire and will only be accessible to related University staff. Results of this 
project may be published, but any data included will in no way be linked to any specific 
participant. Your anonymity will be preserved.  
 
What if I have any questions?  
Questions are always welcome and you should feel free to ask myself, Matthew Horner 
(matthew.horner@study.beds.ac.uk), or the staff supervising the project (Dr Julia Fruer: 
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Julia.Fruer@beds.ac.uk; Dr. John Hough: John.Hough@beds.ac.uk) any questions at 
anytime. 
 
Should you want to participate in this study then please complete the attached consent 
form, which needs to be returned before commencing the study.  
This project has been reviewed and approved by the Ethics Committee of the 
Department of Sport and Exercise Sciences. 
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J – Ethics Documentation 
UNIVERSITY OF BEDFORDSHIRE 
 
Research Ethics Scrutiny  
 
When completing this form please ensure that you read and comply with the following: 
 
Researchers must demonstrate clear understanding of an engagement with the following:  
  
1. Integrity - The research has been carried out in a rigorous and professional manner and due credit 
has been attributed to all parties involved.  
2. Plagiarism - Proper acknowledgement has been given to the authorship of data and ideas.  
3. Conflicts of Interest - All financial and professional conflicts of interest have been properly 
identified and declared.  
 4. Data Handling - The research draws upon effective record keeping, proper storage of date in line 
with confidentiality, statute and University policy.  
5. Ethical Procedures - Proper consideration has been given to all ethical issues and appropriate 
approval sought and received from all relevant stakeholders. In addition the research should 
conform to professional codes of conduct where appropriate.  
6. Supervision - Effective management and supervision of staff and student for whom the 
researcher(s) is/are responsible  
7. Health and Safety- Proper training on health and safety issues has been received and completed 
by all involved parties. Health and safety issues have been identified and appropriate assessment 
and action have been undertaken. 
 
The Research Institutes are responsible for ensuring that all researchers abide by the above. It is 
anticipated that ethical approval will be granted by each Research Institute. Each Research Institute 
will give guidance and approval on ethical procedures and ensure they conform to the requirements 
of relevant professional bodies. As such Research Institutes are required to provide the University 
Research Ethics Committee with details of their procedures for ensuring adherence to relevant 
ethical requirements. This applies to any research whether it be, or not, likely to raise ethical issues. 
Research proposals involving vulnerable groups; sensitive topics; groups requiring gatekeeper 
permission; deception or without full informed consent; use of personal/confidential information; 
subjects in stress, anxiety, humiliation or intrusive interventions must be referred to the University 
Research Ethics Committee.  
 
Research projects involving participants in the NHS will be submitted through the NHS National 
Research Ethics Service (NRES). The University Research Ethics Committee will normally accept the 
judgement of NRES (it will never approve a proposal that has been rejected by NRES), however NRES 
approval will need to be verified before research can commence and the nature of the research will 
need to be verified.  
 
Where work is conducted in collaboration with other institutions ethical approval by the University 
and the collaborating partner(s) will be required.  
 
The University Research Ethics Committee is a sub-committee of the Academic Board and is chaired 
by a member of the Vice Chancellor’s Executive Group, appointed by the Vice-Chancellor and 
includes members external to the University  
 
Research Misconduct: Allegations of Research Misconduct against staff or post graduate (non-
taught) research students should be made to the Head of the Research Graduate School 
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UNIVERSITY OF BEDFORDSHIRE      
 
Research Bid:  Ethical Issues (STAFF RESEARCH) 
 
Section A must be completed by the proposer and the form should then be submitted with a 
copy of the research proposal to the Director of the Research Institute. To be completed 
prior to the onset of any research activity. 
 
Proposer: Dr. Julia Fruer & Dr. John Hough     
Research Institute: Institute for Sport and Physical Activity Research (ISPAR) 
    
 
Proposal short title: The effect of environmental temperature on appetite regulation and 
energy intake during exercise in men 
 
SECTION A To be completed by the candidate 
 
The candidate is required to summarise in the box below the ethical issues involved in the research 
proposal and how they will be addressed. In any proposal involving human participants the following 
should be provided: 
 
• clear explanation of how informed consent will be obtained,  
• how will confidentiality and anonymity be observed,  
• how will the nature of the research, its purpose and the means of dissemination of the 
outcomes be communicated to participants, 
• how personal data will be stored and secured 
• if participants are being placed under any form of stress (physical or mental)  identify what 
steps are being taken to minimise risk 
 
If protocols are being used that have already received UREC ethical approval then please specify. 
Roles of any collaborating institutions should be clearly identified. Reference should be made to the 
appropriate professional body code of practice. 
 
Answer the following question by ringing/deleting  yes or no as appropriate: 
 
1. Does the study involve vulnerable participants or those unable to give informed consent (e.g. 
children, people with learning disabilities, your own students)?     
No 
 
If YES: Have/will researchers be DBS checked? 
    Yes No 
 
2. Will the study require permission of a gatekeeper for access to participants (e.g. schools, self-
help groups, residential homes)?        
No 
 
3. Will it be necessary for participants to be involved without consent (e.g. covert observation in 
non-public places)?          
No 
 
4. Will the study involve sensitive topics (e.g. sexual activity, substance abuse)?   
No 
 
5. Will blood or tissue samples be taken from participants?      
Yes 
 
6. Will the research involve intrusive interventions (e.g. drugs, hypnosis, physical exercise)?  
Yes 
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7. Will financial or other inducements be offered to participants (except reasonable expenses)? 
No 
 
8. Will the research investigate any aspect of illegal activity?  
No 
 
9. Will participants be stressed beyond what is normal for them? 
Yes   
                                                               
10. Will the study involve participants from the NHS (e.g. patients) or participants who fall under 
the requirements of the Mental Capacity Act 2005?    
 
No 
 
If you have answered yes to any of the above questions or if you consider that there are other 
significant ethical issues then details should be included in your summary above. If you have 
answered yes to Question 1 then a clear justification for the importance of the research must be 
provided. 
 
*Please note if the answer to Question 10 is yes then the proposal should be submitted through NHS 
research ethics approval procedures to the appropriate NRES. The University Research Ethics 
Committee should be informed of the outcome 
 
 
Background 
 
Obesity prevention is highlighted as a national priority in Public Health England’s 2015-16 
Annual Plan. As the success of traditional weight management approaches has been 
variable, improved cost-effective approaches are required. This study focuses on the impact 
of altering environmental temperature during exercise.  
A small number of studies suggest that acute exercise in the heat suppresses appetite and 
energy intake to a greater extent than exercise in the cold, but these findings are variable 
and the mechanisms involved are poorly understood (Wasse et al. 2013; Kojima et al. 2015). 
For example, exercise in cold has been shown to attenuate the exercise-induced reduction 
in hunger when compared with exercise in a hot and thermoneutral environment in healthy 
men (Kojima et al. 2015). Furthermore, energy intake (EI) was lower after exercise in a hot 
enviornment compared with thermoneutral environment (Wasse et al. 2013), and higher in 
cold compared with thermoneutral environment (Crabtree et al.; Wasse et al. 2013). 
However, others have not found a difference in EI after exercise in the heat when compared 
with a thermoneutral environment; rather, EI was greater after exercise at a neutral 
temperature, but not in the heat, when compared with a resting control (Shorten et al. 2009). 
Research on the mechanisms involved in explaining changes in appetite after exposure to 
different environmental temperatures has produced conflicting findings. Although cold 
exposure while at rest has been shown to increase total ghrelin concentrations (Tomasik et 
al. 2005), exercise performed in hot or cold environments did not affect acylated ghrelin 
(Shorten et al. 2009; Wasse et al. 2013) or total ghrelin (Kojima et al. 2015). Similalrly, some 
report that exercise in the heat increased PYY (Shorten et al. 2009), while others have 
shown no effect of environmental temperature during exercise on PYY (Crabtree et al. 2015; 
Kojima et al. 2015). In adiditon to the unequivocal findings associated with this line of 
research, the study designs that have been employed have limations, including failing to 
include a direct measure of EI (Kojimia et al. 2015), to a resting control trial (Kojima et al. 
2015; Wasse et al. 2013) and to measure the active form of ghrelin (Kojima et al. 2015). 
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The unique contribution of this proposal to determine the impact of exercise performed in a 
cold, thermoneutral and hot environment on appetite-regulating hormones (acylated ghrelin, 
PYY and Glucagon like peptide-1) and EI. 
The specific aims are as follows: 
• To examine the effect of exercise performed in different environmental temperatures 
on appetite and appetite-regulatory hormones. 
• To examine the effect of exercise performed in different environmental temperatures 
on ad libitum energy intake. 
 
 
Methods 
 
Participants 
Following ethical approval, 15 males aged 18-35 years will be recruited. Prior to data 
collection, all participants will be given an information sheet (see Appendix A) which will 
outline the requirements of the study. Any further information required from the participants 
will be provided before they sign an informed consent sheet (see Appendix B). A Physical 
Activity Readiness questionnaire (PAR–Q) and Pre-test Medical Questionnaire (see 
Appendix C), and a blood screening form (see Appendix D) will also be completed to ensure 
that no participants will complete this study with underlying health concerns or issues that 
would put the participant or the experimenter at risk (e.g. blood borne diseases). The 
participant will be made aware that they are able to withdraw from the study at any point and 
it will not impact them in a negative way. 
 
Preliminary measurements 
Prior to the experimental trials, anthropometric measures of stature (Stadiometer, 
Harpenden, HAR- 92.602, Holtain), body mass (Scales, Tanita, BWB0800, Allied Weighing, 
Conwy, UK) and percentage body fat (via BodPod measurement) will be measured. The use 
of the BodPod will adhere to a standard protocol, following guidance from Easton and Rilley 
(2002). To gain an understanding of habitual breakfast consumption, all participants will be 
asked to complete a brief questionnaire (Appendix E).  
Participants will then be asked to complete a submaximal and maximal exercise test on a 
treadmill in temperate conditions. The submaximal test will consist of 4 x 4 min stages at 
intensities ranging between approximately 30-80% of maximal oxygen uptake (V̇O2max) at a 
gradient of 1% starting at 5 km/h increasing by 1.5 km/h every minute. A maximal exercise 
test will then be completed after a rest of 5-10 min. This protocol will start at a 1% incline and 
the gradient will be increased by 1% every minute until volitional exhaustion. The initial 
speed will be set at the speed corresponding to a heart rate (HR) of approximately 160 beats 
min-1 (measured during the submaximal exercise test). Expired gas will be analysed during 
the entire period of testing using a breath-by-breath cardiopulmonary exercise testing 
system (MetaLyzer 3B, Cortex, Leipzig, Germany) and values of oxygen (VO2) consumption 
and carbon dioxide (VCO2) production will be recorded. Heart rate will also be recorded 
continuously using short-range radio telemetry. Ratings of perceived exertion (RPE) will be 
assessed using the 6-20 Borg scale during the final minute of each stage. V̇O2max will be 
calculated as the maximum V̇O2 value averaged over 60s during the test using a rolling 
average. Subsequently, treadmill speed eliciting 70% V̇O2max will be estimated using the 
submaximal and maximal exercise test data. 
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Experimental Design 
Using a repeated measures cross-over design, participants will complete four conditions in a 
counterbalanced order: 1) exercise in a thermoneutral (20˚C; EX-NEU) environment 2) 
exercise in the heat (30˚C; EX-HEAT), 3) exercise in the cold (10˚C; EX-COLD), and 4) 
resting control in a thermoneutral environment (CON). Each condition will be completed for 
60 min in an environmental chamber and in the fasted state. The exercise will be a 60 min 
treadmill run at the speed elicitng 70% maximum oxygen uptake and at a gradient of 1%. 
Relative humidity will be 50% for all conditions. Upon leaving the chamber, participants will 
rest in a thermoneutral environment for 4 hours and measures of EI, perceived appetite, 
appetite-regulaitng hromones and substrate oxidation will be taken. The study design is 
outlined in Figure 1.  
 
For all main trials, participants will attend the laboratories at ~08:30 after an overnight fast 
(no food or drink for at least 12 hours) and will be instructed not to consume any alcohol or 
caffeine and to have not taken part in any strenuous physical activity for the previous 24 
hours. Participants will also be directed to complete a 24 h weighed food diary prior to their 
first main trial and replicate their dietary intake in the 24 h period before subsequent main 
trials (Appendix F).  
 
 
 
Figure 1. Study design with four conditions. EX-HEAT = exercise performed in the heat; EX-
COLD = exercise performed in the cold; EX-NEU = exercise performed in a thermoneutral 
environment; CON = rest in a thermoneutral environment. 
 
Energy expenditure and substrate oxidation  
Energy expenditure and substrate oxidation will be estimated via online gas analysis 
(MetaLyzer 3B, Cortex, Leipzig, Germany) and indirect calormetry (Frayn, 1983) while in the 
environemntal chamber during the exercise and control trials at 0-10 min (with the first 5 min 
disgauarded from analysis), 30-35 min and 55-60 min and for the first 20 minutes after 
leaving the environmental chamber. For resting measurements, participants will lay supine 
on a bed and the first 5 min of the sample will be disguarded from analysis.  
 
Blood sampling 
On arrival to the laboratory, an intravenous cannula will be inserted into an antecubital vein 
by trained researcher (with an up to date hepatitis B vaccination). Blood samples will be 
collected at 0 (fasted), 1, 1.5, 2, 3, 4 and 5 h. All blood collections will be completed by a 
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trained research student or staff member. Blood samples will be collected into pre-chilled 
EDTA Vacutainers (BD, Oxford, UK). From each sample,  20-μL blood samples will be 
collected into two heparinised microhaematocrit tubes for determination of haematocrit and a 
10 μL sample into a microcuvette for determination of haemoglobin concentration to assess 
changes in plasma volume (Dill & Costill, 1974). One Vacutainer will be immediately 
centrifued at 1500 × g for 10 min at 4°C (Heraeus Multifuge X3R, Thermo Scientific, 
Loughborough, UK). The plasma supernatant will then be placed into separate cryovials and 
stored at −80°C until later analysis of total PYY. To prevent the degradation of acylated 
ghrelin a solution of potassium phosphate buffer (PBS), P-hydroxymercuribenzoic acid 
(PHMB) and sodium hydroxide (NaOH) (this will be 10μL per mL of blood) will be added to 
one EDTA vacuette. This vacuette will then be spun in a refrigerated centrifuge  at 1500 × g 
for 10 min at 4°C. The plasma supernatant will then be placed into a storage tube and 100 
μL of hydrochloric acid (HCL) per 1 mL of plasma will be added to preserve acylated ghrelin 
(Hosoda et al., 2004). Thereafter, the sample will be spun at 1500 × g for 5 min at 4°C prior 
to storage at −80°C until later analysis of acylated ghrelin. 
 
Plasma samples will be analysed for acylated ghrelin PYY and GLP-1 concentrations via 
commercially available enzyme linked immunosorbent assays (ELISA). To eliminate 
interassay variation, samples from each participant will be analysed in the same run. 
Haematocrit and haemoglobin concentrations will also be analysed. 
 
Temperature and humidity 
On arrival at the laboratory, participants will be fitted with a heart rate monitor (Polar, FS1, 
Kempele, Finland), and a rectal thermometer (Henleys, 400H,, Hertfordshire, UK) inserted 
10 cm past the anal sphincter. Humidty and the environmental temperature will be recorded 
every 30 min. Core temperature and skin temperature will be measured every 5 min via a 
rectal thermometer and skin thermistors, respectively. Clothing will be standardised with 
participants asked to wear the same clothing for all of the experimental trials. 
 
Hydration 
All participants will be asked to consume 500 ml (this is ~ 5-7 mL/kg body mass) of water 2 h 
before arrival at the laboratory to promote a euhydrated state (Sawka et al., 2007) Hydration 
status will be measured on arrival before the start of the trial via urine osmolarity to confirm a 
euhydrated state (< 600 mOsmol/kg). During the trial participants will be allowed to consume 
water ad libitum for each condition. Fluid consumed throughout each condition will be 
recorded. Body mass will be measured in the fasted state and post exercise (in order to 
assess the fluid lost during exercise) and at the end of the trial. 
 
Perceived appetite  
Perceptions of hunger, satisfaction, fullness, prospective food consumption and breakfast 
palatability will be assessed using 100-mm visual analogue scales (VAS) every 30 min from 
baseline.  
 
Ad libitum energy intake 
Ad libitum meals will be provided at 1.5 h and at 5 h for the quantification of EI. The 
participants will have 30 minutes to consume the ad libitum meals. The foods provided for 
both meals will be in excess of expected consumption and of precisely known quantity and 
nutrient composition. At 1.5 h, participants will be provided with an ad libitum buffet-type 
breakfast meal where participants will be presented with an array of breakfast foods for 30 
min during which time they will be instructed to eat until satiety is reached. The breakfast will 
consist of foods and drinks considered regular choices for breakfast are of varied 
macronutrient composition (i.e., breakfast cereals, milk, bread, croissants, spreads, yogurt, 
fruit, juice, cold meats, and cheese). An ad libitum pasta meal will be provided at 5 h. This 
will consist of pasta (uncooked 500 g) and tomato sauce (500 g) (total energy content: 1990 
kcal) cooked and prepared according to standardised manufacturer’s preparation guidelines. 
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The meals will be presented in the same way for each trial and each participant. For 
example, the pasta will be presented in a standardised large bowl and with a standardised 
spoon. A standardised plate and cuttlerly (fork, spoon and knife) whereby the participants 
can scoop the amount desired onto the plate will also be provided.  
 
The food and drink items in the ad libitum meals will be weighed before and after in order to 
measure EI using the same set of kitchen scales (Salter,HoMedics Group Ltd, UK). Total 
kilojoules, along with the quantity of consumed carbohydrate, protein, and fat and the 
percentage of energy intake from solid foods and drinks will be recorded. In addition, relative 
energy intake (REI) will be calculated by correcting postexercise energy intake for the 
energy cost of the exercise session above the resting energy expenditure. 
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Risks and how they will be minimised/avoided 
 
1. Informed consent - All participants will be provided with an information sheet (Appendix A) 
detailing the nature and purpose of the study. A consent form (Appendix B) will be read and 
signed by participants before any testing commences. 
 
2. Confidentiality - All data and information collected regarding the participants will be 
securely stored on a password protected computer and hard copies will be stored in a locket 
filing cabinet at the University of Bedfordshire.  If publication of the study is achieved the 
participants will be informed and all data will be anonymous and not linked to individual 
participants. 
 
3. Anonymity - All results and information collected will be securely stored at the University 
of Bedfordshire.  Only relevant staff members will have access. As previously mentioned if 
this research is published all data will be anonymous. All participants will be identified using 
unique codes, rather than using names. The data collected will be linked to specific 
participants, however only senior members of the reserach team will have access. 
 
4. Rectal thermometer – This study requires core temperature to be measured via a 
disposable rectal thermometer that will be placed 10cm past the anal sphincter. The 
thermometer will be sterile and the participants will insert the thermometer themselves in a 
private area. Instructions will be provided verbally on how to do this. The participant will 
always be accompanied by an experimenter during this procedure. The experimenter will 
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remain outside the door of the area being used by the participant. The participant will be 
wearing a HR monitor that will be conitinually monitored by the experimenter. This will allow 
the experimenter to monitor for an incident of a raised heart rate caused by increase stress 
in the participant or anaphalytic shock (an extremely low probability to occur). The door will 
remain unlocked in case medical attention is required if the participant suffers anaphylactic 
shock. 
 
5. Exposure to extreme heat or cold – Core temperature will be monitored throughout all 
trials using a rectal thermometer to prevent this reaching dangerous levels (2˚C elevation 
above baseline/and elevation above 39.7˚C. There are risks associated with of inserting 
anything into the body can cause shock (e.g., the rectal probe); specific safety precautions 
are carried out in case of any medical emergencies to ensure the participant is safe. These 
include wearing a HR monitor in order for the researcher to identify if anaphlactoid shock 
occurs if HR drops dramatically. Furthermore, the insertion will occur in a private room in 
which the door will not be locked in case the researcher needs to enter should complications 
occur. If anaphylactoid shock does occur the participant will be placed in the supine position 
with their feet elevated to regain lucidity. Core temperature will be recorded every 5 minutes 
but will be monitored more regularly throughout the protocol in case a dramatic rise occurs. 
 
6. Physical stress during exercise - Participants will be informed of the exercise protocol and 
all safety procedures will be explained before testing commences. A safety mat will always 
be present behind the treadmill and clear of any equipment, in order to minimise the risk of 
injury. A first aider will be present at all times within the laboratories so that if an incident 
occurs, first aid will be immediately provided. A researcher will be present at all times during 
exercise to ensure participants are not in any discomfort. Exercise will be terminated if 
participants feel ill or are in discomfort or pain. 
 
7. VO2max - The study requires a measurement of VO2max where participants are required to 
run to volitional exhaustion. Risks involved may be vomiting and feeling faint. The participant 
will be monitored carefully throughout the maximal test and can stop at any point. Those with 
the following conditions will be excluded from the study for their own safety: musculoskeletal 
injury that has affected normal movement within the last month, disturbance of vision, 
congenital heart disease, uncontrolled exercise-induced asthma, diabetes, epilepsy and 
chronic obstructive pulmonary disease (COPD). As it is not feasible to list every medical 
condition, it is possible that those with other medical conditions may be excluded from the 
study once identified. Participants will be informed of the exercise protocol and all safety 
procedures will be explained before testing commences. A first aider will be present at all 
times within the laboratories so that if an incident occurs, first aid will be immediately 
provided. At least two researchers will be present at all times during exercise to ensure 
participants are not in any discomfort. Exercise will be terminated if participants feel ill or are 
in discomfort or pain and will be monitored.  
 
8. Use of treadmill – Participants will be made aware that appropriate footwear must be worn 
to avoid trips and slips. The treadmill will change between different speeds during the VO2max 
therefore the participants will be counted down (3, 2, and 1) to avoid unexpected changes. 
When demounting from the treadmill it will be made certain that the belt has fully stopped. In 
case of a fall a blue padded mat will be positioned behind the treadmill to minimise injury. 
The participants will be made aware that they can withdraw at any point.  
 
9. Blood sampling - Venous blood sampling from the antecubital vein will be carried out in 
accordance with the BASES blood sampling safety procedures. This will ensure the safety of 
both participants and the research team. Laboratory coats, goggles and disposable gloves 
will be worn every time blood samples are being handled. The person collecting the blood 
will be trained and have an up-to-date Hepatitus B vaccination. Particular attention will be 
paid to cover any cuts on the hands using waterproof dressings. Likewise, cannulas used 
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during the cannulation method will not be re-used, but immediately put into a sharps bin. If 
containers or vials become externally contaminated, they will be cleaned immediate 
 
All participants will be pre-screened with the use of a blood screening form (see appendix D) 
prior to blood sampling to clear any risk of blood borne viruses, which could put the 
researchers at risk. If the participant answers ‘yes’ to any of the questions, the participant will 
not be eligible for the blood sample procedure and will be excluded from the study. 
 
10. Blood analysis - The bloods will need to be analysed, risks involved cross - 
contamination. There may be chemical spills when using the ELISA. Therefore the 
experimenters will be trained and any spills will be cleaned immediately following the 
appropriate standard operating procedures (SOPs) and risk assessments (RAs). 
 
11. Disinfecting equipment - Researchers will use disposable gloves when disinfecting 
equipment. The cortex mask and turbine will be cleaned by immersing the Turbine in Milton 
solution. Leaving it for 10 minutes. Then rinsing the Turbine in tap water in a beaker. DO 
NOT HOLD UNDER A RUNNING TAP as this will damage the delicate turbine. Change the 
water in the beaker, and repeat. Finally, rinse the turbine in a beaker of distilled water. Dry 
as much as possible by waving in air (do not use mechanical driers or towels or tissues).  
Dip the Housing in Milton solution, then rinse under a running tap and dry. Do not clean the 
Electronic assembly. This must not get wet. Re-assemble as shown in diagram. Rinse the 
mask in warm water, then immerse in Milton for 10 minutes. Rinse thoroughly (Under the 
tap). Dry with paper towels. 
 
12. Allergies to test meals - To reduce the risk of participants having any kind of reaction to 
the meals provided, a health screen questionnaire (Appendix E)  will be completed by the 
participants before beginning of the study. This will identify any allergies the participants may 
have to the meals, e.g. lactose or gluten intolerance. If any participant's allergies to any of 
the foods provided in the test meals, they will not be able to participate in the study. 
 
13. Bodpod - Claustrophobia could occur when inside the Bodpod. However the participant 
will be made aware of the emergency release button and told that they can leave the 
Bodpod at any time if they feel uncomfortable. Participants will also be provided with a robe 
to minimsie possible feelings of embarrassment that are associated with wearing minimal 
clothing.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Proposer declaration 
I understand that I cannot collect any data until the application referred to in this form 
has been approved by all relevant parties. I agree to carry out the research in the 
manner specified. If I make any changes to the approved method I will seek further 
ethical approval for any changes. 
 
Signature of Proposer: Dr. Julia Fruer Date: 18/10/2016 
 
Signed (Staff Applicant): Dr. Julia Fruer Date: 18/10/2016 
          Dr. John Hough      Date: 18/10/2016 
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This form together with a copy of the research proposal should be submitted to the Research 
Institute Director for consideration by the Research Institute Ethics Committee/Panel  
 
Note you cannot commence collection of research data until this form has been approved 
 
 
 
SECTION B To be completed by the Research Institute Ethics Committee: 
 
Comments: 
 
 
 
Reviewer:  
 
 
Recommendation of Reviewer:  
 
 
Signature of Reviewer:    Date:  
 
 
 
 
Signature Chair of Research Institute Ethics Committee: 
 
 
 
 
 
 
Dr Laura Charalambous       Date:  
 
 
 
 
 
Dr Laura Charalambous       Date:  
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K – Statistical Output 
Relative Energy Intake 
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PYY 
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Acylated Ghrelin 
 
 84 
 
Overall Appetite 
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L – Mean + SD For Graphs Presented 
Mean body temperature 
 
PYY 
 
Acylated Ghrelin 
PID MBT_CON_0
MBT_CON_3
0 MBT_CON_1
MBT_CON_1.
5 MBT_CON_2
MBT_CON_2.
5 MBT_CON_3
MBT_CON_3.
5 MBT_CON_4
MBT_CON_4.
5 MBT_CON_5
Mean 34.9692143 34.7026429 34.4773571 34.351125 34.3706821 34.2578571 34.3628036 34.5745536 34.5010714 34.5352857 34.5394464
SD 0.25274013 0.37831294 0.46672288 0.49875381 0.51483042 0.58454358 0.65584821 0.86726841 0.561882 0.55661889 0.54983997
PID
MBT_COLD_
0
MBT_COLD_
0.5
MBT_COLD_
1
MBT_COLD_
1.5
MBT_COLD_
2
MBT_COLD_
2.5
MBT_COLD_
3
MBT_COLD_
3.5
MBT_COLD_
4
MBT_COLD_
4.5
MBT_COLD_
5
Mean 35.5015 35.286375 35.6494375 35.2331875 34.9053281 34.6877969 34.6720781 34.6543125 34.6390625 34.5244063 34.4937188
SD 0.44498443 0.95374737 1.00459841 0.31320549 0.28768757 0.19409366 0.34892687 0.40285442 0.46285098 0.59229468 0.73367824
PID MBT_NEU_0
MBT_NEU_0.
5 MBT_NEU_1
MBT_NEU_1.
5 MBT_NEU_2
MBT_NEU_2.
5 MBT_NEU_3
MBT_NEU_3.
5 MBT_NEU_4
MBT_NEU_4.
5 MBT_NEU_5
Mean 35.8295 36.7668125 37.3495 35.8319375 35.1766875 34.9265156 34.8693594 34.7035938 34.7328906 34.6870625 34.5931719
SD 0.28271894 1.59056679 1.61117703 0.3754883 0.35727457 0.23094452 0.17570686 0.42906914 0.29122988 0.35324406 0.29242068
PID MBT_HOT_0
MBT_HOT_0.
5 MBT_HOT_1
MBT_HOT_1.
5 MBT_HOT_2
MBT_HOT_2.
5 MBT_HOT_3
MBT_HOT_3.
5 MBT_HOT_4
MBT_HOT_4.
5 MBT_HOT_5
Mean 35.87775 36.638375 37.6049375 36.3965469 35.3972188 34.9410469 34.7789531 34.5770969 34.8459531 34.6587656 34.6227031
SD 0.19774569 0.19207081 0.20255272 0.30477551 0.17513447 0.3021785 0.4533425 0.83513356 0.45534958 0.66561623 0.71425857
Time 0 1 1.5 2 3 5
Average 0 -6.3645 -17.575 38.84883 28.62933 18.45783
SD 0 19.2699 27.07996 64.77196 29.28007 29.27907
Time 0 1 1.5 2 3 4 5
Average 0 0.8815 -19.113 25.25733 19.06567 10.49683 6.109
SD 0 34.87431 21.92728 37.05521 32.33712 40.93828 43.76261
Time 0 1 1.5 2 3 4 5
Average 0 14.543 10.081 36.73867 18.91533 13.825 1.1855
SD 0 26.20719 34.72284 20.55676 25.40799 28.28546 28.90986
Time 0 1 1.5 2 3 4 5
Average 0 5.046333 -19.2908 28.0465 6.089833 3.393167 -11.8302
SD 0 24.1237 16.20606 40.18566 26.63713 47.66723 42.94442
CONTROL
COLD
NEUTRAL
HOT
 87 
 
Overall Appetite 
 
Time 0 1 1.5 2 3 5
Average 0 9.811333 2.009 -15.5145 -40.2563 -13.1288
SD 0 20.08815 38.56375 23.55532 26.59144 37.28348
Time 0 1 1.5 2 3 4 5
Average 0 -7.406 4.579667 -25.8545 -40.3472 -11.7765 -2.567
SD 0 13.06359 20.5145 6.979979 10.24531 58.38009 28.74664
Time 0 1 1.5 2 3 4 5
Average 0 -26.1927 -24.4413 -33.7038 -39.2935 -46.4348 -17.5522
SD 0 29.23986 29.99248 11.17763 19.30002 10.70991 19.13409
Time 0 1 1.5 2 3 4 5
Average 0 2.859667 4.366667 -12.7027 -22.4123 -17.7975 11.84433
SD 0 32.32574 20.94331 20.99489 24.26556 26.37252 29.71372
CONTROL
COLD
NEUTRAL
HOT
OVERALL
_CON_0
OVERALL
_CON_1
OVERALL
_CON_1.
5
OVERALL
_CON_2
OVERALL
_CON_2.
5
OVERALL
_CON_3
OVERALL
_CON_3.
5
OVERALL
_CON_4
OVERALL
_CON_4.
5
OVERALL
_CON_5
Mean 73.34375 80.9375 87.15625 10.34375 15.1875 31.09375 34.40625 45.75 50.84375 65.96875
SD 17.02621 13.50446 7.537925 5.493401 12.75858 20.40787 25.45126 24.47958 30.35944 18.58159
OVERALL
_10_0
OVERALL
_10_1
OVERALL
_10_1.5
OVERALL
_10_2
OVERALL
_10_2.5
OVERALL
_10_3
OVERALL
_10_3.5
OVERALL
_10_4
OVERALL
_10_4.5
OVERALL
_10_5
Mean 67.34375 77.0625 79.3125 13.0625 14.8125 24.125 31.03125 38.375 51.15625 56.875
SD 27.59786 12.95097 15.6626 10.64756 8.439649 16.82101 20.47186 23.58685 23.14818 22.52419
OVERALL
_20_0
OVERALL
_20_1
OVERALL
_20_1.5
OVERALL
_20_2
OVERALL
_20_2.5
OVERALL
_20_3
OVERALL
_20_3.5
OVERALL
_20_4
OVERALL
_20_4.5
OVERALL
_20_5
Mean 69.625 69.40625 82.8125 11.40625 19.15625 25.9375 38.5625 45.84375 53.59375 57.5
SD 15.96816 20.42317 15.04027 10.60318 17.61439 25.64028 28.43217 31.08052 25.09337 23.06087
OVERALL
_30_0
OVERALL
_30_1
OVERALL
_30_1.5
OVERALL
_30_2
OVERALL
_30_2.5
OVERALL
_30_3
OVERALL
_30_3.5
OVERALL
_30_4
OVERALL
_30_4.5
OVERALL
_30_5
Mean 70.4375 74.6875 83.3125 20.78125 21.65625 29.6875 40.28125 51.46875 60.09375 67.59375
SD 18.5293 15.85974 9.629521 22.78723 15.70654 20.91469 23.38438 23.64259 18.20515 20.50999
